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Abstract

SYNTHESIS OF CYCLEN BASED RECEPTORS FOR PYRENE
DYES AND THEIR USE IN SEPARATIONS BIOTECHNOLOGY
By Vivek Kaushik, Ph.D.
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2011

Major Director: Vladimir A Sidorov, Ph.D.
Associate Professor Department of Chemistry

A number of purification techniques such as adsorption, centrifugation, chromatography,
extraction, distillation, filtration, precipitation etc. to name a few, are commonly used for
the purification. However, due to a constant need of purification of even more complex
crude mixtures, be it reaction mixtures, various proteins and DNA from cell extracts or
medicinal compounds and fragrances from plant extracts, scientists needed to consistently
develop new and improved techniques of purification. One such great advancement in the
field of chromatography was the development of affinity chromatography. It revolutionized
the field of bioseparations technology, and the dream of single stage purification of
complex biological substrates such as proteins, enzymes, co-enzymes, DNA, RNA etc. was
realized.
Development of various precipitation techniques involving phase tags, acid-base induced
precipitation, host-guest interactions, chemoselective precipitation etc. further simplified

xiv
purification procedures for few substrates. However, only a few examples of chemoselective
precipitation are known in literature.1, 2
In 2005, our group synthesized a cyclen-based receptor.9 This receptor showed very strong
and very specific affinity for the pyrene based dyes (HPTS, APTS, PTA) under physiological
conditions, similar to that of the natural receptors for their ligands. Upon interaction with the
dye, this artificial receptor formed a low solubility complex which had micromolar stability.
Various structure and activity studies established the essentiality of the macrocyclic structure
of the receptor for the dye recognition. We further decided to study the effect of various
substituents on the aromatic ring on the binding and quenching affinity of the receptor. A
series of receptors bearing electron-withdrawing and electron-donating substituents were
synthesized (receptor 4-6). We also synthesized a receptor having aliphatic groups instead of
aromatic groups attached to the thiourea group (receptor 7) as well as a receptor lacking
thiourea linkage (receptor 8). The results of fluorometric titrations of these receptors were
consistent with the previous structure and activity studies, as the receptors having electron
withdrawing nitro- and bromo substituents (receptor 4 and 6 respectively) on the aromatic
groups (have increased π-stacking) were better receptor than cyclen 1. Interestingly, the
receptor 5, bearing an electron-donating methoxy groups on the aromatic ring, has also
shown an increase in the affinity towards HPTS. We speculated that this increased affinity
could be due to the higher affinity of receptor 5 towards Na+ which was essential for the
proper arrangement of the receptor binding arms. The receptor with the aliphatic chain
(receptor 7) showed a complicated complexation process and showed variable fluorescence
quenching at various receptor concentrations. This behaviour was probably due to the
formation of complexes of a various stochiometries. Expectedly, the receptor lacking thiourea
group (receptor 8) did not show any interaction.

xv
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interaction, we hypothesized that this receptor-dye pair can be used in the selective separation
of substrates by chemoselective precipitation. We reasoned that if the substrate of interest can
be attached to the dye, this dye-substrate conjugate then can be selectively precipitated from
the reaction mixture upon addition of the receptor. We tried our concept for the separation of
lactose from lactose/sucrose mixture. Being a reducing sugar, lactose was labeled with APTS
dye, whereas sucrose that lacks the reducing end, remained unmodified. Application of the
cyclen receptor to this mixture resulted in precipitation of APTS-lactose conjugate, leaving
sucrose as the only component in the solution.10 By coupling APTS dye with lactose via an
imine bond, we were able to successfully isolate unmodified lactose from the conjugate by
subsequent hydrolysis of the conjugate.10

Scheme 1. Structure of a) fully reduced lactose-APTS conjugate b) partially reduced lactose-APTS conjugate.

xvi
Next, we decided to use this dye-receptor pair in affinity chromatography. We hypothesized
that if the receptor can be immobilized on some solid support then it can be specifically used
as an affinity support for the substrates which are attached to the pyrene-based dyes. A new
receptor with a functional group on the cyclen core was needed to immobilize the receptor on
the solid support. The receptor 11 (fig. 2.A) having an aromatic primary amine group was
synthesized. This receptor was successfully immobilized on the NHS activated agarose resin.
A series of fluorometric experiments were performed to determine the specificity and binding
ability of the affinity support towards the pyrene dyes. Initial results of these experiments
indicated that the affinity support was very effective as indicated by almost 95% fluorescence
quench of a solution of 50 nM HPTS and affinity resin (fig. 2.B).

Figure 2. A) Structure of receptor 11; B) Emission spectra of 50 nM HPTS dye in the presence of the resin and
(or) free or immobilized receptor 11.

This work has opened several new venues of research, and the applicability of this dyereceptor pair in the fields of biochemistry, pharmacology, cell biology etc. will be explored.

Chapter 1
Separations Technology-Affinity chromatography and chemoselective
precipitation
1.1 Introduction

Since ancient times, people have used methods of separating and purifying chemical
substances for improving the quality of life. The extraction of metals from ores and of
medicines from plants is older than recorded history. Gold was mined as early 2 nd and 3rd
century AD in India as proved by the gold objects found in Harappa and Mohenjo-daro.
Fragrances were first extracted from various plants and flowers by ancient Egyptians. One
very common and modern example which revolutionized human history is purification of
crude oil. It is a mixture of various hydrocarbons and each has a significant use. Crude oil
is purified by fractional distillation into individual hydrocarbons such as gasoline, diesel,
jet fuel, lubricating oil, asphalt etc.

Nowadays, discovery of most of the new compounds results from synthesis in the
laboratory. Laboratory preparation of a compound often yields a crude mixture containing
some quantities of the unreacted starting materials as also impurities that are by-products
from side reactions. A substance that occurs in a natural source is also rarely present as a
single entity in that source. The first demand on the chemist or the biochemist is the
isolation of the pure compound from the crude mixture that has resulted from either the
laboratory synthesis of the compound or its extraction from one of its natural sources. The
chemist or the biochemist proceeds to study the properties or details of the structure of a
compound only after it has become available in the pure state.

1

A number of purification techniques such as adsorption, centrifugation, chromatograph y,
extraction, distillation, filtration, precipitation etc. to name a few, are commonly used for
the purification. However, due to this constant need of purification of complex crude
mixtures like reaction mixtures, various proteins or DNA from cell extracts, scientists
needed to develop new and improved techniques of purification. One such great
advancement in the field of chromatography was the development of affinity
chromatography. It revolutionized the field of bioseparations technology and as a
consequence, the goal of single stage purification of complex biological substrates such as
proteins, enzymes, co-enzymes, DNA, RNA etc. was realized. Development of various
precipitation techniques involving phase tags, acid-base induced precipitation, host-guest
interactions etc. further simplified purification procedures for few substrates.

1.2 Affinity Chromatography:
Affinity chromatography is a purification technique based on highly specific and reversible
interactions between two molecules. Interactions between antibody and antigen, protein and
metal-ion, enzyme and substrate, dye and protein etc. are few very common examples of such
interactions which formed the bases of affinity chromatographic separation of these
substrates from the complex mixtures.

Scheme 1.1. A schematic representation of various affinity chromatography steps.
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1.2.1 Immunoaffinity Chromatography (IAC)
The concept of immunoaffinity chromatography goes back as early as 1924 when Engelgardt
suggested "the method of fixed partner" and used immobilized antibodies to catch free
antigen in fluids.11 In early 1950s Campbell et al. successfully isolated antibodies with
antigens immobilized on azide-activated cellulose.12 Even though, the idea of immunoaffinity
chromatography originated in early twentieth century, it took several decades to expand the
use of the method for the separation of different types of antigen and antibody fragments. 13-15
Discovery of monoclonal antibodies in 1970s greatly accelerated development of IAC.16
IAC is a separation method based on specific and reversible interaction between an antigen
(Ag) and a matrix bound antibody (Ab), and is capable of effecting high yield single stage
purification of many biomolecules.11 IAC can be used in the separation of various
biomolecules such as proteins of pharmaceutical interest,17-20 vaccines, small biomolecules21
and virtually anything for which monocolonal antibody (MAb) can be made. Separation by
IAC involves a number of steps. First is to find an ideal support, followed by activation and
immobilization of affinity ligand on the support. This support is then loaded with the crude
extract having desired product and finally eluted to separate the desired product from other
impurities.
Matrix:
The matrix is the solid support on which antibodies are immobilized for IAC. An ideal
immunoadsorbent should be macroporous, stable, highly functionalized, easy to activate,
hydrophilic and inert.22-24
The most popular support matrix for affinity chromatography is beaded agarose. The
favorable characteristics of agarose include its high porosity, hydrophilicity, chemical
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stability, and its relative inertness towards nonspecific adsorption.25 However, agrose is not
very stable.26 This problem was overcome by cross linking agarose with epichlorohydrin.26 A
major disadvantage of beaded agarose is its inability to withstand high pressure gradients,
even when cross linked.
Another popular support is polyacrylamide porous beads. These are prepared by the
copolymerization of acrylamide and N-N’methylene-bis-acrylamide. Polyacrylamide gels are
hydrophilic, free of fixed charge, stable in aqueous environment between pH 2-10, and
tolerate dilute organic acids.26 A major disadvantage is microporosity which hinders the
efficient immobilization of Ab.16
Poly(HEMA), a copolymer of hydroxyl methacrylate and ethylene glycol dimethacrylate;
azalactone functional copolymer beads, made by copolymerization of azlactone functional
vinyl monomers with acrylamides or acrylates; and cellulose are other supports used in
affinity chromatography.
Silica is the inorganic support used in IAC. However, pure silica, due to irreversible
adsorption and denaturation of many biomolecules, has limited use in immunoaffinity
chromatography.16 Synthesis of modified silica, covered with a hydrophilic surface layer,
made it more compatible for IAC. High stability and its ability to withstand high pressure
have made silica an ideal support for high performance immunoaffinity chromatography
(HPIAC).27
Activation and Coupling:
All the matrices discussed above are highly functionalized; however, not all of them are
reactive enough for the immobilization of the Ab on the matrix. Hence, these functional
groups need to be activated in order to attach Ab to the solid support. Several activation

4

strategies have been successfully used to activate the solid support. These methods fall under
two basic categories: 1) those that produce randomly oriented immobilized Abs 2) those that
produce more uniformly oriented Abs. Proper orientation of Ab is necessary for effective
binding to the Ag. Antibodies have Y shaped structure with antigen binding region (Fab
region) located in the tip of arms. The base of the Y is called Fc region (fig. 1.1).28

Figure 1.1. Structure of antibody showing Fab and Fc regions and mechanism of recognition of antigen by
190
antibody.

Abs immobilized using Fc region retain full activity and bind with the Ag. However, Abs
immobilized on the solid support using Fab region, loses partial or complete ability to bind
the Ag depending on whether one or both the Fab regions of the Ab are used for
immobilization (fig. 1.2).29

5

Figure 1.2. Idealized representation of Ab immobilized by random coupling procedure.

Cyanogen bromide (CNBr): It is the most popular and very effective method for the
activation of solid supports.30, 31 One big advantage of using CNBr is its ability to activate
most matrix surfaces under aqueous conditions. However, CNBr is volatile and toxic, hence,
newer procedures employing cyanylating agents32 such as p-nitrophenylcyanate (pNPC) or 1cyano-4-(dimethyl-amino)-pyridinium tetrafluoroborate (CDAP) have been introduced. One
disadvantage of CNBr-activated supports with respect to Ab immobilization is the slow
leakage of the protein over time.33 This can be attributed to the inherent instability of the
isourea bond through which Ab is coupled to the support.32
Sulfonyl chlorides: Tresyl chloride and tosyl chloride are the two most commonly used
sulfonyl chlorides for the activation of solid supports.34 Tresyl chloride is preferred as it
forms sulfonates more readily and is easily displaced at neutral pH and 40C.34
Carbonyldiimidazole: Another activation procedure for hydroxyl groups uses 1, 1’carbonyldiimidazole to introduce activated carbamates as the reactive species.35, 36
Periodate oxidation: Supports containing vicinal diol groups can be activated by sodium
metaperiodate, oxidizing the diols to aldehyde group. Amino group on the protein reacts with
the aldehyde group under mild conditions (aqueous buffer at pH 7-8) and forms an imine
bond which is subsequently reduced with sodium borohydride or sodium cyanoborohydride
to produce a stable secondary amine bond.
6

Activation by hydrazine, azalactone and N-hydroxy succinimide are some other methods
used to activate solid supports having functional groups other than –OH group.

Scheme 1.2. Selected activation and coupling pathways: A) Cyanogen bromide; B) Sulfonyl chloride; C)
Carbonyldiimidazole; D) Periodate oxidation

Methods for oriented Ab immobilization:
All of the above mentioned methods results in random orientation of coupled Ab, which tend
to reduce its ability to bind Ag. Several schemes for achieving oriented coupling have been
reported. One such scheme involves immobilization of Protein A on the solid support, which
has strong affinity for the Fc region of many IgG subclasses.37, 38 This protein is then cross
linked to Ab with dimethyl pimelidate. Using Protein A agarose, Sisson and Castor reported
complete Ab attachment and full Ab activity.38
Another approach involves oxidation of carbohydrate moiety of IgG with periodates to
produce reactive aldehyde groups, located mostly within the hinge region of Ab molecule.
The modified IgG is either coupled to a surface containing amines or more reactive hydrazide
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groups.39,

40

Prisyazhuoy et al., utilized the SH groups of the Fab’ fragment to create an

oriented Ab fragment.41
Loading:
The objective of loading is to retain only the desired product on the support. Usually precolumn clarification of the crude extract is done prior to loading in order to prevent fouling or
clogging of the column. This solution is then introduced in the column. The flow rate of the
crude solution is limited either by the mechanical rigidity of the support matrix or the time
required for the diffusion of the product into the pores of column matrix. In stirred tanks, the
matrix and crude mixture are mixed together for a fixed time, after which solid phase is
collected.16 One variation of stirred tank methods uses magnetic affinity beads which can be
separated from other insoluble compounds by collecting them in a magnetic field.29, 42
Washing:
Following the loading, column is washed with physiological buffers (e.g. phosphate buffered
saline, pH 7.2). The column is washed to remove unbound impurities present in the fluid
volume of the column as well as those bound nonspecifically to the affinity support.
However, one must be careful with washing as excessive washing can result in product loss.
Thus, it may be necessary to compromise between yield and purity.
Elution:
In this step, product is recovered from the column by using a solvent that reduces affinity of
Ag to Ab. A number of procedures have been described. These includes use of either high 43
or low pH,16, 44 chaotropic agents such as KSCN,45 organic solvents such as ethylene glycol,46
DMSO,47 or acetonitrile,48 high49 or low ionic strength,50,

51

increased temperature,52

denaturing agents11 such as 8M urea or 6M guanidine and others. Alternatively, gentler
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elution methods that have been described include electrophoretic elution,53 pressure induced
elution54 and metal ion elution18 in which Ag-Ab binding depends on the presence or absence
of a metal ion.
Regeneration and cycling:
Since Ab and MAb are expensive, it is absolutely necessary to regenerate the immunoaffinty
columns for further use to make it economically viable process. In this step column is washed
with the solutions to remove elution buffers, as well as component of the crude extracts that
have bound nonspecifically to the column and have not been released by either washing or
elution. One protocol suggests a routine wash with 2M KCl/6M urea after each use.11
Applications of IAC:
The most important application of IAC is protein purification. IAC has been used both for
laboratory scale and preparative scale purification of proteins.29 At laboratory scale cost is not
a primary concern as the scale is small, and main focus is placed on the development of new
purification methods for the substances that have not been previously purified. In contrast,
the cost is the most significant factor at preparative scale purification. This requires careful
selection of support, the coupling chemistry, the ligand and the elution and washing
conditions such that the column capacity is retained over repeated cycles.29 Other uses
involve use in assays and subtractive chromatography.
1.2.2 Immobilized Metal-Ion affinity chromatography (IMAC)
The basis of the method was first introduced by Helfferich55 in 1961 when he showed that
metal ions immobilized on the resins can be used for the separation of the compounds which
form complexes with them. Everson and Parker56 were the first, who adopted immobilization
of the chelating compounds for the separation of metalloproteins. The method became
9

popular through the research work of Porath,57, 58 and Sulkowski,59-62 who laid the foundation
of this technique, mainly on its use for the separation and isolation of proteins.
In IMAC, metal ions are loaded on a sorbent or matrix using multidentate chelating groups
which are covalently attached to the matrix. Chelating groups and metal ions form
complexes, as a result of which metal ions are secured for subsequent interaction with the
compound to be resolved. To this end, the metal ions must have free coordination sites in
order to allow the interaction with proteins. These interactions between metal-ions and
proteins are extremely complex in nature and can involve electrostatic, hydrophobic and
donor-acceptor interactions. It has been found that histidine, tryptophan and cysteine residues
in proteins are critical for protein separation in IMAC,63 due to the strong interactions of these
residues with the metal ions. Since there are a limited number of cysteine residues on the
surfaces of proteins, histidine plays the role of a major target for metal ion complexation.64, 65
Metal Ions:
Metal ions can be divided into three categories: Hard, borderline or intermediate and soft
ions, based on the principle of hard and soft acids and bases (HSAB) described by Pearson. 66
Fe (III), Al (III), Ca (II), Mg (II), and K (I) belongs to the hard metal ions group, which show
preference for oxygen, aliphatic nitrogen and phosphorus. Soft metal-ions such as Cu (I), Hg
(II), Ag (I), etc., prefer sulfur containing ligands and borderline metal-ions Cu (II), Ni (II), Zn
(II), and Co (II) coordinate aromatic nitrogen, oxygen and sulfur.64 The most commonly used
metal-ions are transition ones, Cu (II), Ni (II), Zn (II), Co (II), and Fe (III), especially Ni (II)
as it provides a coordination number of six, electrochemical stability under chromatographic
conditions, borderline polarizability and redox stability.22
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Chelating Ligands:
In IMAC metal-ions are immobilized on the matrix using chelating ligands. These are
compounds that form complexes with metal ions and retain them on the solid support.
Various types of multidentate ligands are commonly used for the immobilization of metalions.55 The stability of metal ion complex with a chelating ligand depends upon multiplicity
of the chelate, hence order of stability is penta> tetra> tridentate58, 64, 65 which implies a lower
metal-ion leakage in higher dentate chelate. However, the stronger metal-chelate complex
comes at the expense of weaker protein binding. Therefore, the order of biomolecule
adsorption strength is tridentate> tetradentate> pentadentate.58,

65

As a result, most of the

investigations have focused on the use of tri and tetradentate ligands which hold on the metal
ions sufficient strength without sacrificing too much binding affinity of the metal ion to the
proteins.
Triazine dyes such as Cibacron blue, Cibacron red, Procion brown etc. are also used as
chelating agents in IMAC.67-69 However, their use is very limited as they form weaker
complex compared to multidentate chelates. Also, the dye ligands are used as affinity ligands
themselves, which implies that part of biomolecule adsorption on this kind of immobilized
metal affinity matrix may be through the dye affinity adsorption and not completely due to
the metal ion interaction.68-70
Matrix:
For an adequate use in IMAC, the matrix must be stable, have functional groups on the
surface that are easy to derivatize, hydrophilic, have high porosity with fairly large pore size,
allow the use of high flow rate and provide a stable bed. Classical stationary phases are based
on soft gel matrices, such as agarose, beaded cellulose or cross linked dextran.71, 72 However,
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these matrices are compressible and restricted to low flow rate, hence their use on the large
scale in industry is limited.65
Silica is an ideal rigid support, as it can be manufactured with large pores and narrow pore
size distribution to efficiently increase the macromolecular transfer inside the matrix. 73
However, nonspecific adsorption of proteins to silica by complex hydrophobic interactions
and instability under basic conditions (pH>8.0) limits the use of silica in IMAC. In order to
overcome these problems silica-based matrices are normally coated with hydrophilic
polymers such as agarose,65, 74, 75 dextran74-77 and chitosan73, 78, 79. Not only such coatings reduce
the nonspecific adsorption through the increased hydophilicity, but they also increase
chemical stability and loading capacity of the coated silica.
Activation and ligand immobilization conditions:
While immobilizing ligand on the matrix, care should be taken that only the least critical
regions of the ligand are used for immobilization. Reaction conditions should be chosen in
such a way that the loss of ligand activity is minimal. Steric hindrance between the ligand and
the protein is another major concern, as active sites of the biological molecules are often
located deep within the three-dimensional structure of the molecule which can severely
hinder protein binding capability of the ligand. This problem can be overcome by use of
spacer arms between matrix and the ligand molecule. An ideal spacer arm must be
bifunctional so that it can react with both matrix and the ligand. It should not have any active
center to cause extra non-specific adsorption.23
Two alternative procedures may be followed. The matrix is first activated with an activation
agent, and then spacer arm is attached covalently to the matrix through the active points.80
The ligand is then reacted with the other end of the spacer molecules. Alternatively, the
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ligand-spacer arm conjugate is first synthesized and then attached to the matrix in one single
step.
Cyanogen bromide, activation of –OH groups to oxiran groups with bisoxiranes,
epichlorohydrin, or epoxy bromopropane and oxidation of two vicinal cis-hydroxyl groups to
aldehyde using sodium peroxide are few commonly used activation methods.30, 80, 81
Loading:
The interactions between protein and the immobilized metal ion are very complex in nature
and vary from electrostatic interactions between charged biomolecule and (a) positively
charged metal-ions, (b) negatively charged sites remaining on the matrix, hydrophobic
interactions between biomolecule and the matrix surface and/or donor-acceptor interactions
of the exposed amino acid residues with the metal-ions.23, 81-83 Various factors such as the
nature of chelating ligand, metal ion, surface amino acid composition, nature of buffer salts,
pH, and ionic strength of the loading buffer determine the dominant interaction over the
others during loading. It has been found that at higher ionic strengths protein adsorption
become more selective.84-86 The protein adsorption is controlled by the pH of the medium as
protons affect the net charge on the immobilized metal-ions as well as the surface properties
of the proteins resulting in an altered retention behavior.58, 84, 85, 87, 88
Elution:
In this step, buffer solutions of a pH value lower than the pKa of surface exposed electron
donating amino acids or high ionic strengths are used to elute proteins from the column. If
harsher conditions are needed, a high displacement agent e.g., imidazole or stronger metal
chelating agent e.g., EDTA could be used.58 Some elution protocols involving the
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simultaneous use of both imidazole addition and pH decreasing gradient in order to achieve a
better chromatographic resolution have been described.64
Application:
Protein purification:
Histidine residues are found on most of the natural proteins, but due to their mild
hydrophobicity, only few of them are located on the protein surface.65 Also, there are steric
concerns as well, as proper accessibility is required to form stable complex between the
histidine residue and the metal ion chelate conjugate.
Hochuli et al.89 showed that affinity tags attached to the C- or N-terminus of the recombinant
proteins can be used for the purification of proteins by IMAC. Usually histidine tags of
various lengths have been used as affinity tags. His6 having six consecutive histidine residues
is the most commonly used affinity tag.89-96 Histidine tagging and IMAC have become a
routine for easy first-time isolation of newly expressed proteins.
IMAC and protein refolding:
Inclusion bodies produced in E. coli are composed of densely packed denatured protein
molecules. These proteins are biologically inactive and need elaborate solubilization,
refolding and purification to yield the functionally active product. But these processes are
highly cumbersome, result in poor recovery and account for the major cost in the production
of recombinant proteins from E. coli.97
Recently, a new IMAC based matrix assisted method has been developed for the production
of soluble and functional proteins from inclusion bodies. It involves production of tagged
proteins in inclusion bodies which are then solubilized, denatured and immobilized on a
charged resin. These immobilized proteins are then renatured or refolded (using various
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denaturing and renaturing procedures)98-106 on the matrix followed by elution of protein from
the matrix in its native and soluble form.
Other uses of IMAC involve separation and enrichment of phsphoproteins and
phosphopeptides using Fe (III) and Ga (III) embedded matrices.107
1.2.3 Dye-ligand affinity chromatography
Most of the affinity chromatography techniques involve immobilization of antibodies, amino
acids, proteins, nucleic acids, oligonucleotides, enzymes, coenzymes and cofactors on the
solid matrix.108,

109

These ligands are expensive due to the high cost of production and/or

extensive purification steps. Moreover, as use of harsh conditions can cause degradation of
the ligands, it is difficult to immobilize certain ligands, as standard conditions are not
sufficient to immobilize these ligands on the support. Also, precaution is required during the
sorption and elution steps, as the use of harsh conditions can damage the affinity ligand.
The dye-based ligands provide exciting alternative to the natural counterparts for the specific
affinity chromatography. These dyes are synthetic, inexpensive, commercially available
compounds that can be easily immobilized on the matrices bearing hydroxyl groups. Dyebased ligands are able to bind most types of proteins, especially enzymes, in some cases in a
remarkably specific manner.
Chemical structures of the dye-based ligands:
Triazinyl-based dyes are the most widely used in protein purification (fig. 1.3.a).Cyanuric
chloride (1, 3, 5-trichloro-syn-triazine) forms the core structure of the dye. Due to the
presence of the chlorine atoms these three carbons become highly susceptible to nucleophilic
substitution reactions.24 Chromophore molecules are easily attached to this molecule to form
dichlorotriazinyl dyes. The procion MX (fig. 1.3.b) series is a typical example of this type of
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dyes.110,

111

By further reaction of these molecules with other nucleophilic substituents,

monochlorotriazinyl dyes are synthesized. Cibacron112,113

and Procion H110,

111, 114

are

examples of such dyes (fig. 1.3.c). Two dichlorotriazinyl molecules can be coupled with a
bifunctional molecule to form bifunctional triazinyl dyes. Procion H-E is an example of this
type of dye (fig. 1.3.d).114

Figure 1.3. Structure of some of reactive dye molecules. a) cynauric chloride b) Procion MX series c) Cibacron
and Procion H d) Procion H-E

The latest development in the dye-ligand affinity chromatography is the use of “biomimetic
dyes”.115 These are synthetic dyes which mimic the structure and binding of natural biological
ligands of the targeted protein. These dyes retain advantages of the parent dye but have
improved specificity towards the target protein. The first biomimetic dye was prepared by
linking benzamidine to the reactive chlorotriazine ring via the diaminomethylbenzene
group.116 It was used for the specific separation of trypsin from the chymotrypsin. 117 Isolation
of kallikrein from a crude pancreatic extract and purification of alkaline phosphates from calf
intestinal extract are few examples where biomimetic dyes were used for specific purification
of the target protein.118
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Matrix:
As discussed in previous sections, an ideal matrix should be stable, have high porosity and
fairly large bead size, have functional groups, exhibit minimal nonspecific binding to the
biomolecules and hydrophilic. Most commonly used matrices are cross linked agarose beads,
cellulose, sephadex, acrylamide gels and controlled pore glass.71, 72
Ligand Immobilization:
The choice of coupling methods and the reaction conditions depends on both the matrix and
the ligand. The least critical regions of the dye should be used for immobilization to ensure
minimal interference with the specific interactions between immobilized ligand and the target
molecule. As the active sites of the biological molecules are often located deep within the
three dimensional structure of the molecule, spacer arms are frequently placed between the
matrix and the ligand to ensure their accessibility to the target.
Nonreactive dyes can be coupled to the matrix by usual activation methods. Many reactive
dyes are directly immobilized on the matrix by direct reaction between the reactive groups
(mainly hydroxyl groups) on the matrix and the dye molecules (through chloride or fluoride
atoms) on triazinyl groups.119-122
Loading:
Before loading, the column is washed with the equilibrating buffer solution, followed by
loading of target protein on the column in a buffer solution having same pH and ionic
strength as that of the equilibrating buffer solution. The pH and ionic strength of buffer is
optimized for each specific case. Usually phosphate buffers are used as they reduce non
specific protein-dye-ligand interactions. When the low conductivity buffers are required,
MOPS, MES, HEPES or Tris buffers are often chosen. Metal ions (Mg2+, Ca2+, Zn2+, Fe3+,
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Al3+etc.) may be added into the buffers to increase the affinity of the dye-ligand to the target
protein, and/or to stabilize the protein molecules in the aqueous media. However,
precipitation of the metal ions, which is pH dependent, may cause problems; therefore
necessary precautions should be taken into consideration. Temperature is another factor that
affects affinity interactions. Therefore, it should be kept constant at the optimum value both
at the sorption and elution steps. The linear flow rate of the buffers should be optimized.
There are two protocols that can be followed in the adsorption step. The first one is known as
the “positive binding” method. This method involves use of an adsorbent that specifically
binds the target protein along with few other contaminating proteins. These contaminating
proteins are then flushed out of the column using equilibrating buffer before the elution step.
Alternatively, a “negative binding” protocol, in which contaminating proteins are adsorbed
on the column preferentially, can be used.123,

124

Higher target recovery and purity can be

achieved in a two step process, in which the protein mixture is passed through a negative
binding column, and effluent of this column is then directed to the second, positive binding
column.
Elution:
The objective of elution step is to completely elute the desired protein, at the same time
minimizing the amount of the contaminating proteins which may be co-eluted. Elution of the
bound proteins may be achieved by nonselective or selective processes. In the nonselective
elution, pH, ionic strength, or polarity of the elution buffer is changed to elute protein of
interest. If the electrostatic interactions are dominant, an increase in pH may be sufficient to
elute the bound protein molecules. If the cation exchange is important, a very sharp effect of
ionic strength is observed on protein elution.55 If hydrophobic interactions are predominating,
the polarity of eluting buffer can be reduced to promote elution. Chaotropic agents are highly
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effective for protein elution.125However, chaotropes may cause significant degree of protein
denaturation, and therefore they are not recommended to be used at elution step. Chaotropic
solutions are effective to remove residual proteins for regeneration of dye-ligand sorbents for
repeated use.
In selective elution, the affinity eluants are used, which compete with the dye ligand for the
same binding site on the adsorbed target protein. Nucleotide cofactors such as NADP+,
NADH, ATP and AMP have been used to elute dehydrogenases and other nucleotide
dependent enzymes from immobilized Cibacron blue F3GA and other reactive dyes.126
1.3 Chemoselective precipitation
Only a few examples of such chemoselective precipitation are known in literature. 1, 2 Of most
prominent examples, precipitation of C60 with calixarenes and related macrocycles,
developed by Atwood and coworkers, serves as a proof of efficiency of such methodology. 3, 4
While being efficient, Atwood’s protocol lacks versatility as it is only applicable to a specific
pair of substrate and macrocycle, and is not applicable to biological substrates, which must be
extracted from the aqueous medium. A precipitation methodology for isolation of nonbiological targets has been introduced by Wilcox et al..127, 128, 129 It will be discussed in detail
in the next section.
1.3.1 Precipitons:
In 2001 Craig Wilcox introduced a new concept of “precipiton” assisted separation of
product from a reaction mixture. A “precipiton” is a group of atoms (molecular fragment)
that is purposefully attached to a reactant molecule and can be isomerized after the reaction to
facilitate precipitation or the phase transfer of the attached product.5-7 Various studies showed
that cis-stilbenes were more soluble than the trans-stilbenes in various organic solvents. This
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varying solubility formed the basis for the development of the precipiton.8 The biphenylderived alkenes 3Z and 3E were prepared by Wittig reaction (scheme 1.3).5

Scheme 1.3. Synthesis of precipiton 3Z. a) KHMDS, THF, -780C, 81%; b) 1. tBuLi, THF, -780C; 2. DMF, -78-00C,
97%; c) NaBH4, EtOH, 00C, 98%

Alkene 3Z was freely soluble in common organic solvents such as EtoAc, THF, Et2O,
CH2Cl2, CHCl3 and C6H5CH3 while 3E isomer was virtually insoluble in all those solvents.
Before using these auxiliary groups for isolating products, various isomerization conditions
such as photochemical methods (with or without sensitization),130 isomerization using
diphenyl disulfide131 and isomerization using iodine with benzoyl peroxide under illumination
by a sun lamp were examined. However, photochemical methods were not satisfactory as the
reactions were slow and side products were generated during the course of reaction. In
contrast, the last two methods were very effective and afforded excellent yields of
precipitated products.
Isolation of Isoxizolines using Precipitons:
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Isoxazolines are a class of compounds synthesized by [3+2] cycloaddition reaction between
alkenes and nitrile oxides (scheme 1.4).132 Furoxans, formed by the dimerization of nitrile

Scheme 1.4. A general scheme for the synthesis of isoxazolines by [3+2] cycloaddition reaction between
alkenes and nitrile oxides.

oxides, are troublesome byproducts and condition worsens when the excess of nitrile oxide is
required to push the reaction to completion.133 Flash column chromatography is used to purify
the isoxazoline product. Wilcox et al. hypothesized and successfully used precipitons for the
isolation of isoxazolines from furoxan by product. To do so, first several alkenoates were
attached to precipiton 3Z by an ester linkage (scheme 1.5).

Scheme 1.5. Synthesis of precipiton bound alkene substrate for cycloaddition with nitrile oxide.

These were then subjected to cycloaddition with nitrile oxides in diethyl ether (scheme 1.6).
After the reaction, the reaction mixture was washed with water and volatile components were
removed. This residue was then dissolved in THF and Z/E isomerization of the precipiton
auxillary was induced by adding diphenyl disulfide and heating the solution. The solvent was
removed after isomerization, the crude residue obtained was washed with Et2O, MeOH, or
hexanes to remove any by product, and sparingly soluble pure products were isolated by
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filtration. Precipiton-bound products were isolated in good yields and high purity (scheme
1.7).

Scheme 1.6. A general scheme for the synthesis of precipiton bound isoxazoline product by [3+2] cycloaddition reaction
between precipiton bound alkenes and nitrile oxides.

Scheme 1.7. Illustration of the “precipiton” process for isoxazoline isolation. a) A solution of tert-butylnitrile is
added to an ethereal solution of precipiton bound alkene. b) The Et 2O is removed to afford a crude residue. c) The
crude residue is diluted with THF and one equivalent of diphenyl disulfide was added. d) The solution is heated at
reflux to cause isomerization and product precipitation. e) The THF is removed and the solid is washed with
hexanes, Et2O, or methano; to afford clean solid.
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Finally, precipiton was cleaved from the product by methanolytic transesterification in THF
by methanol/triethylamine (scheme 1.8). The resulting methyl ester isoxazolines were
obtained in high yields and purities.

Scheme 1.8. Methanolytic cleavage of the precipiton bound product to furnish precipiton E-3 and methyl ester of
desired product.

Precipiton-assisted isolation of α-substituted β-ketoesters:
In order to demonstrate the usefulness and further extend the scope of precipiton method in
separations technology, Wilcox et al. used precipitons in the separation of α-substituted βketoesters.129 These are the family of compounds which serve as useful intermediates in the
preparation of heterocyclic compounds134 and can also be chemoslectively and
diasteroslectively reduced to form aldol-type products.135
Acetoacetate ester 4Z was prepared by treatment of 3Z with diketene and catalytic amount of
DMAP (scheme 1.9).

Scheme 1.9. Acetoacetate ester 4Z was synthesized by reacting precipiton 3Z with diketene in the presence of catalytic
amount of DMAP.
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The β-ketoester 4Z was deprotonated with sodium hydride to generate the enolate, which was
then treated with an excess of alkylating agent. Upon completion of alkylation, the reaction
mixture was partitioned between EtOAc and aqueous NH4Cl. The organic layer was
evaporated and residue was dissolved in Et2O or CCl4 containing I2 and benzoyl peroxide to
cause isomerization. Further work-ups and trituration of crude in ether, hexanes or methanol
resulted in isolation of precipiton bound product in good yields and purities over 95%
(scheme 1.10).

Scheme 1.10. Synthesis and isolation of precipiton bound product. 1) Alkylation of 4Z to afford precipiton bound
product. 2) Isomerization of reaction crude to yield precipiton bound product.

The precipiton was then cleaved by methanolysis (MeOH/TEA in THF, reflux 1-2 h) (scheme
1.11). This furnished the methyl β-ketoesters in good yields and high purities.

Scheme 1.11. Methanolytic removal of precipiton to give free product.
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Precipiton assisted purification of Baylis-Hillman adducts:
The Baylis-Hillman reaction is a C-C bond forming reaction between an activated alkene and
an aldehyde in the presence of a tertiary amine, tertiary phosphine, or chalcogenide (scheme
1.12).136 To push the reaction to completion one of the components must be used in excess,137
which, in turn, will require purification of the product by column chromatography. However,
the precipiton approach provides the liberty to use excess of one of the reactants without
having to run a column for purification.

Scheme 1.12. A general scheme for the synthesis of Baylis-Hillman product by reaction of an aldehyde with an
activated alkene.

Acrylate 5Z was prepared by treatment of 3Z with acryloyl chloride in the presence of
triethyl amine (scheme 1.13). The acrylate 5Z was treated with catalytic amount of

Scheme 1.13. Synthesis of precipiton acrylate 5Z by reacting precipiton 3Z and acryloyl chloride in the presence
of TEA

DABCO and excess of aldehyde at room temperature.138 Upon completion of the reaction of
the reaction the crude mixture was diluted with a suitable solvent and treated with I2 and
dibenzoyl peroxide or PhSSPh.Various work-ups and trituration with hexanes, ether, or
MeOH resulted in precipiton bound Baylis-Hillman producst in good yields and high purity
(scheme 1.14).
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Scheme 1.14. Synthesis and isolation of precipiton bound product. 1) Reaction of 5Z with aldehyde in the

The
precipiton-bound
Baylis-Hillman
products
were cleaved
from 2)the
precipitonofbyreaction crude
prescence
of catalytic amount
of DABCO to furnish
precipiton
bound product.
Isomerization
to yield pure precipiton bound product.

hydrolysis (LiOH in THF-H2O). The acids were isolated by filtration of the insoluble
precipiton, acidification of the solution, followed by extraction with EtOAc. Removal of the
EtOAc furnished the desired acid in good yields and purities of ≥95% (scheme 1.15).

Scheme 1.15. Hydrolysis of precipiton bound product in the presence of LiOH in H 2O-THFto afford precpiton
and product

1.4 Cyclen based receptors for pyrene dyes and their use in separation technology
In 2005 our group synthesized a cyclen based receptor.9 This receptor had a macrocyclic
structure and was comprised of four naphthylthiourea groups tethered to a cyclen core via an
ester linkage (fig. 1.4). This receptor showed very strong and very specific affinity for the
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Figure 1.4. Structure of cyclen 1, HPTS, APTS and PTSA dyes.

pyrene based dyes (HPTS, APTS, PTA) (fig. 1.4) under physiological conditions. Upon
interaction with the dye, the receptor formed an insoluble complex which had micromolar
stability (Ka-10-6), and the complex formation resulted in quenching of the dye fluorescence.
Isothermal calorimetry (ITC) and molecular mechanics simulation identified π-stacking
between the aromatic units of the receptor and the planar core of the dye as the major driving
force for the complex formation (scheme 1.16).

Scheme. 1.16. A) Envisoned binding mode for cyclen 1 and HPTS dye. The backside thiourea unit of cyclen 1
is truncated for clarity. This representation is given for pictorial purpose only. B) Structure of cyclen 1-HPTS
complex optimized by molecular mechanics (AMBER) simulations in the water box. Water molecule omitted
for clarity.
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Since this receptor-dye pair formed an insoluble complex of micromolar stability upon
interaction, we decided to use this receptor-dye pair in developing a new separations
technology. We reasoned that if the substrate of interest can be attached to the dye, this dyesubstrate conjugate then can be selectively precipitated from the reaction mixture by adding
receptor in the reaction mixture. Alternatively, if this mixture is passed through a column
carrying immobilized receptor on the solid support, the labeled substrate can be selectively
purified. We hypothesized that this receptor-dye pair can be used in the selective separation
of substrate by chemoselective precipitation as well as by affinity chromatography. This work
is discussed in detail in the following chapters.
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Chapter 2
Synthesis of cyclen-based receptors for pyrene dyes
2.1. Introduction
In 2005, Winschel et al. were trying to develop a new biomembrane leakage assay,139 as the
current assays had some inherent shortcomings. The liposome-based pH-stat fluorometric
assay is an assay routinely used for identification of physiologically relevant ionophores.140, 141
In the context of this discussion, ionophores are the compounds that assist in the transport of
ions across cell membranes. In this assay, a controlled amount of the base and potential
ionophore is added to a suspension of liposomes containing a pH-sensitive dye, 8hydroxypyrene-1,3,6-trisulfonate (HPTS, pyranine),142-144 or sometimes fluorescein.145 The
resulting pH gradient across the bilayer membrane causes the efflux of hydronium ions and
builds up an electrostatic potential. This potential can be compensated by the efflux of anions
or influx of cations. If the compound of interest mediates such ion transport, the efflux of
hydronium ions continues altering the intravesicular pH and the fluorescence of the reporter
dye. The kinetic trace obtained from the dye response thus reflects the ionophoretic activity
of the studied compound.

Scheme 2.1. A) pH-Stat experiment; B) Membrane leakage assay
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While being rapid and reliable, the pH stat assay provides little information on the
mechanism of ion transport.146 A membrane leakage assay addresses some mechanistic
aspects by distinguishing selective ion transport from nonslective leakage through oversized
pores.147, 148 This assay utilizes the ability of calcein or carboxyfluorescein (CF) dyes to selfquench their fluorescence emission at ~100 mM concentration.(ref) In a typical experiment, a
set of large unilamellar vesicles (LUVs) containing the concentrated dye is challenged with
the compound of interest. In the case of selective ion transport, little change in fluorescence is
observed, whereas the larger pore formation results in the dye release, its subsequent dilution,
and emission increase. However, this assay requires high concentration of the dye (100 mM)
and at such a high concentration the membrane properties could be altered, as well as the
buffer capacity, and interactions of the dye with ionophore become possible. Another assay
used to detect endovesiculation requires high concentration (40mM) of quencher p-xylenebis-pyridinium bromide (DPX) (fig. 2.1).149 In such high concentrations DPX has been
reported to affect the fluidity of negatively charged membranes, to alter the size of large
unilamellar vesicles (LUVs), and to lower the bilayer phase transition temperatures. 150 As a
result, both above mentioned assays cannot deliver an accurate picture of the effects produced
by the ionophore on the biological membrane.

Figure 2.1. Structure of DPX.

Therefore, we hypothesized that a compound capable of selective binding to the HPTS at
micromolar concentrations, impermeable to the bilayer membrane, and capable of quenching
HPTS fluorescence would provide the basis for improved assays. This led to the synthesis of
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cyclen 1 receptor which binds to HPTS and quenches its fluorescence at micromolar
concentrations under physiological conditions. To gain more information on the
thermodynamics of the complexation process, a series of isothermal titration calorimetry
(ITC) experiments were performed. ITC is a quantitative technique that can directly measure
the enthalphy (∆H) of binding event, whereas the binding affinity (Ka) and, subsequently, the
free energy (∆G) can be calculated through the fitting of the titration data into the binding
isotherm. The last thermodynamic parameter, entropy (∆S), can be calculated through the
subtraction of the free energy of binding from the enthalpy. The stoichiometry of the
complex formation can be accessed from the appearance of the binding isotherm. As a result,
all important thermodynamic parameters can be obtained from a single ITC experiment.
In the case of ITC titration of the solution of HPTS with the solution of cyclen 1, the
formation of two distinct types of complexes was observed (fig. 2.2.A and 2.2.B).The
assessed thermodynamic data for these complexes are summarized in Table 1. The first
complex shows 1:1 stoichiometry, whereas the second complex corresponds to the overall 1:4
HPTS/cyclen 1 stoichiometry. These two complexes have different strengths and are driven
by different thermodynamic forces. The originally formed 1:1 complex is 2 orders of
magnitude stronger than the subsequently formed 1:4 complex. Whereas the formation of the
1:4 complex is an enthalpically driven process, the 1:1 complex formation is almost entirely
an entropically driven process. The entropically driven 1:1 binding is consistent with the
solvophobic effect most likely accompanying π- π rather than hydrogen-bonding or
electrostatic interactions.151 A much weaker 1:4 complex formation is a mostly enthalpically
driven process accompanied by a smaller positive entropy change. This second complexation
step is probably due to the electrostatic and/or hydrogen-bonding interactions of cyclen 1
molecules with the initially formed 1:1 complex. Although the solvophobic effect plays a role
in the 1:4 complex formation as well, the diminished entropy change likely stems from the
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decrease in the degrees of freedom for the large aggregate formed from several molecules.
Noteworthy, no additional inflection points between 1:1 and 1:4 pyranine/cyclen 1 ratios
were observed in the ITC plot, suggesting that the second binding process proceeds via a
concerted cooperative mechanism.
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Figure 2.2. Microcalorimetric characterization of interactions of cyclen 1 with pyranine and calcein in methanol. (A) Raw
data for the titration of a 0.25 mM solution of HPTS with a 10 mM solution of cyclen 1. (B) Integrated data from (A),
corrected by the heat of cyclen 1 dilution, normalized to moles of injectant and plotted as a function of cyclen 1/pyranine
ratios (solid squares). A continuous line represents the data fit in two sets of sites binding model. (C) Raw data for the
titration of a 0.25 mM solution of calcein with a 10 mM solution of cyclen 1. Note the difference in vertical scales for plots
(A) and (C). (D) Integrated data from (C), corrected by the heat of cyclen 1 dilution, normalized to moles of injectant and
plotted as a function of cyclen 1/calcein ratios.

Table 2.1. Thermodynamic Parameters Assessed for the Complexation of Pyranine with Cyclen 1 in Methanol

N
1.28 ± 0.014
3.57 ± 0.050

Ka(M-1)
(3.16 ± 0.75) × 106
(1.46 ± 0.12) × 104

ΔG (kcal/mol)
−8.87 ± 0.17
−5.68 ± 0.05
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ΔH (kcal/mol)
−0.41 ± 0.05
−3.87 ± 0.08

TΔS (kcal/mol)
8.47
1.81

The specificity of the cyclen 1 towards the HPTS dye was further established by the lack of
interaction of cyclen 1 with fluorescein-related dyes (fig. 2.3). These dyes are negatively
charged and have aromatic cores like HPTS dye, however, these dyes are not planar as the
benzene ring is tilted out of plane of the second aromatic unit. The π-stacking of these cores
with the aromatic units of the cyclen 1 was not expected to be efficient, and indeed, the ITC
titrations of calcein with cyclen 1 showed no apparent binding except protonation of the basic
receptor with the acidic dye (fig. 2.2.C and 2.2.D). These experiments prove that the planar
aromatic core of the dye is essential for its recognition by cyclen 1.

Figure 2.3. Structure of various fluorescein dyes.

2.2. Structure-activity relationship studies
The original receptor cyclen 1 was comprised of four naphthylthiourea groups tethered to a
cyclen core via ester linkages (fig. 1.4 structure of cyclen 1). This tetrafold macrocyclic
structure of cyclen 1 with multiple functional groups placed into the specific positions was
essential for HPTS recognition, as established by the results of various structure-activity
studies. In the first study, the acyclic naphthyl thiourea 2 (fig. 2.4.A), which mimics the
structure of a single arm of cyclen 1, was titrated into the solution of HPTS instead of cyclen
1. This arm replica did not bind the dye to any measurable extent, proving the necessity of the
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macrocyclic arrangement of the receptor for the dye recognition. Another study indicated that
ester linkers are essential for the binding as ester groups coordinate to the physiologicallyabundant Na+ ion and bring the four arms closer to each other which further assists in the
complexation of the dye.152, 153 Indeed, when receptor 3 (fig. 2.4.B) lacking ester linkages was
used for HPTS binding, a 15-fold decrease in Ka values was observed compared to the cyclen
1. This hypothesis was further supported by a three-fold drop in cyclen 1 affinity to HPTS in
Na+-free buffer. In another study, NH-Boc synthetic precursor (fig. 2.4.C) showed no
noticeable binding affinity to HPTS. This proved essentiality of the thio(urea) functionality as
well as the terminal aromatic units for the recognition of the dye by the receptor. All these
studies proved beyond any doubt that the receptor having a macrocyclic structure and
specifically placed functional groups is essential for the recognition of the dye by the
receptor.

Figure 2.4. Structure of compounds used in structure and activity studies. A) acyl naphthyl thiourea 2 B) receptor 3
C) Nh-Boc synthetic precursor
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2.3. Synthesis of new receptors
The results of various structure and activity studies shed light on some interesting facts
regarding necessity of macrocyclic structure of the receptor for the dye recognition. We
further decided to explore the effects of structure of the receptor on its ability to bind the dye.
The effects of various substituents on the aromatic unit of the receptor were not studied
previously. Hence, a series of receptors having different X and R groups as shown in fig. 2.5
were synthesized and their fluorometric titrations were carried out to determine their affinity
towards pyranine dye.

4

Figure 2.5: Structure of various receptors synthesized having different X and R groups

Receptors 4-8 were synthesized according to scheme 2.2. The synthesis began with N-Bocethanolamine, which underwent a substitution reaction with bromoacetyl bromide to give
compound i (step a) in 90% yield. The compound i was then subjected to substitution reaction
with the cyclen to afford compound ii (step b) in 56% yield. We call compound ii as the
precursor, as it was used to synthesize all the receptors 4-8, by reacting it with various
isothiocynate compounds. Subsequent deprotection of the precursor with trifluoroacetic acid
(TFA) furnished compound iii (step c) in 100% yield. The compound iii was used without
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any purification in the synthesis of receptors 4-8. The compound iii was subjected to addition
reaction under basic conditions with various isothiocynate to furnish receptor 4-7 and reacted
with benzoyl chloride to yield receptor 8 in yields ranging from 22-76% (step d).

Scheme 2.2. a) Bromoacetyl bromide, Et3N, CH2Cl2, rt, 5 hrs, 90%; b) cyclen, CH3CN, rt, 72 hrs, 56%; c)
TFA/CH2Cl2, rt, 6 hrs; d) RNCX, i-PrOH/EtOH or THF, Et3N or i-Pr2EtN, 6-48 hrs, 22-76%

2.4. Fluorometric titrations and results
The receptors 4-8 synthesized according to the scheme 2.1 had different X and R groups. The
receptors 4-7 have thiourea tethers but they have different R groups on the aromatic moieties.
The receptor 3-5 varied in the electronic nature of the subtituent group attached to the
aromatic ring e.g. receptor 4 had an electron-withdrawing nitro group on the aromatic ring,
receptor 5 was bearing an electron-donating methoxy group on the aromatic ring and receptor
6 had a weakly electron-withdrawing bromine atom on the aromatic unit. The receptor 7
lacked the aromatic unit and had an n-butyl group attached to the thiourea group instead. The
receptor 8 had an amide group instead of thiourea group. In order to understand the effect of
these different groups on the binding ability of the receptor, fluorometric titrations were
carried out. In a typical experiment, an aqueous solution (2 mL) containing 50 nM HPTS, 100

36

mM NaCl, 10 mM NaxH3-xPO4 (x = 1, 2; pH 6.4) was placed in a thermostated
spectrophotometric cell set at 250C. The solution was gently stirred during the experiment.
Prior to the spectrometric recording, 20μL of 25-5000 μM solution of receptors 4-8 in DMSO
were added to the cell giving the final concentration of the receptors in the range of 2.5-500
μM. The emission spectra were then recorded with the excitation wavelength of 405 nm. The
emission maxima at 510 nm were monitored. Binding constant and the maximum emission
loss with the confidence interval values were then computed (table 2.2) using a homemade
nonlinear regression curve fitting program.

Table 2.2. Binding constants and maximum fluorescence loss assessed for the complexes of HPTS with cyclen
based receptors from Fluorometric titrations in PBS

Receptor

cyclen 1

Ka (M-1)
Imaxrel loss (%)

4

5

6

7

8

(2.6 ± 0.3) × 106

(7.2 ± 0.8) × 106

(9.0 ± 1.2) × 106

(4.2 ± 0.8) × 106

Not determined

No interaction

90.9 ± 1.6

98.5 ± 2.3

77 ± 1.1

93.3 ± 3.1

Variable

0

The receptors 4 and 6 featured strong and weak electron-withdrawing groups respectively,
t

and their affinity to HPTS was higher than that of cyclen 1 as indicated by their respective Ka
and Imaxrel loss values. Receptor 4 with the strong electron-withdrawing nitro group turned out
to be the most efficient receptor in terms of the fluorescence quenching. HPTS dye is
negatively charged due to the presence of three sulfonate groups and an OH group with low
pKa. The electron-withdrawing groups remove electrons from the aromatic ring of the
receptor’s arms, making them electron-depleted, which in turn resulted in a stronger πstacking of the receptor with the negatively charged HPTS dye.
Interestingly, receptor 5, bearing an electron-donating methoxy groups on the aromatic ring,
has also shown an increase in the affinity towards HPTS. While we didn’t have an exact
explanation for this observation, we speculated that the receptor 5 has a higher affinity to Na+
cation, which was essential for the proper arrangement of the receptor binding arms. Since
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the actual affinity of ester groups to Na+ is not very high,152, 153 a certain portion of receptor
molecules always remain uncoordinated and hence less efficient in terms of HPTS binding. In
case of receptor 5, such a portion of molecules was lower than that for the cyclen 1, and more
efficient apparent binding of the receptor 5 could be due to this more efficient Na+
coordination. Although plausible, this explanation is a mere speculation as the further
investigation of the observed phenomenon was beyond the scope of this study.
Receptor 7 showed variable fluorescence quenching at various concentrations which
suggested that a complex binding mechanism was in operation. One possible explanation is a
formation of complexes of a various stochiometries. We have already seen two types of
complexes in case of HPTS and cyclen 1 binding (1:1 and 1:4). As the receptor has four
binding arms and HPTS has six binding sites (four sulfonates and two faces of aromatic
core), it is plausible that a series of complexes ranging from 6:1 (one dye and six receptor
molecules) to 1:4 (one receptor and four dye molecules) can be formed. In all these
complexes, the electronic environment of the dye is different which results in different extent
of quenching. This is in line with the observed variation in the quenching extent as the
receptor concentration was increased in titration series (fig. 2.6).

Figure 2.6. Fluorometric titrations of 50 nM PBS solution of HPTS with receptor 7. Experimental data is normalized
to the percentage of unbound dye fluorescence
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Receptor 8 had amide linkages in the place of thio(urea) linkages of the receptors 1-7, and it
did not show any binding to the HPTS dye. This observation signifies the importance of
thio(urea) group for the dye recognition by the receptor.
2.5 Conclusions
Receptor 4 and 6 with electron-withdrawing substituents were the better receptors, signifying
the importance of π-stacking in the complexation process. The highest Ka value observed for
the receptor 5 and lower quenching was somewhat intriguing and no exact explanation was
possible for its complexation behavior.

Receptor 7 with butyl groups showed variable

quenching extent in the titration series, attributable to the formation of several complexes
with different stoichiometries. Receptor 8 lacking the thio(urea) group did not bind the dye,
showing the essentiality of these groups for HPTS recognition.
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Chapter 3
Chemoselective Precipitation of Lactose from a Lactose/Sucrose Mixture:
Proof of Concept for a New Separation Methodology
3.1 Introduction
Affinity chromatography,154, 155, 156, 157 immunoprecipitation158, 159, 160 and electrophoresis161, 162,
163

remain the most common purification techniques for biological targets. Although the

efficiency of these techniques has advanced to a level where virtually any biological substrate
can be isolated in pure form, large scale purification of such substrates is cost-prohibitive.164,
165

Furthermore, nearly all techniques, except for immunoselective precipitation,166 require a

substantial excess of gel matrices or solid phase, which may pose environmental problems in
association with large scale purifications. On the other hand, non-specific precipitation
techniques such as protein salting out167,

168

or precipitation with glycine or trichloroacetic

acid169 do not require excessive amounts of reagents yet they provide rapid large-scale
isolation of crude mixtures of proteins. Obviously, such precipitation methods show little
selectivity as they rely on non-specific desolvation of proteins that are present in the mixture.
A precipitation methodology that does not require excessive amounts of components, yet is
capable of targeting specific functional groups that are present or introduced into the
substrate, may become a valuable addition to both highly selective microscale separations
and nonselective large scale separation techniques.
To our surprise, only a few examples of such chemoselective precipitation are known in
literature1,

2

Of most prominent examples, precipitation of C60 with calixarenes and related

macrocycles, developed by Atwood and coworkers, serves as a proof of efficiency of such
methodology.3,

4

While being efficient, Atwood’s protocol lacks versatility as it is only

applicable to a specific pair of substrate and macrocycle, and is not applicable to biological
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substrates, which must be extracted from the aqueous medium. A precipitation methodology
for isolation of non-biological targets has been introduced by Wilcox et al..127,

128, 129

In this

methodology, a substrate of interest is allowed to react with a “precipiton”: an auxiliary
stilbene-based molecule, solubility of which can be modulated by isomerization from highly
soluble cis-form to insoluble trans-form. After the reaction, the conjugate is converted into
insoluble form, the precipitate is collected, and the substrate in recovered through solvolysis.
This methodology is applicable to isolation of lipophilic compounds, however, it cannot be
used for separations of highly polar biological substrates due to the reaction conditions that
require organic solvents of low polarity.
While our new methodology utilizes purification approach similar to that described by
Wilcox, this methodology is developed for aqueous medium and therefore especially suitable
for isolation of biological substrates.
Recently, we identified a family of artificial cyclen-thiourea receptors that form complexes
with pyrene-based dyes under near-physiological conditions.9,

170

These complexes feature

micromolar stability and diminished solubility in water and methanol compared to the
intrinsic solubility of the dye and receptor alone.9 More interestingly, the cyclen-based
artificial receptors were highly selective for the pyrene scaffold, while at the same time
tolerating considerable structural variations in peripheral positions on the dye. We reasoned
that the conjugates of these dyes with biological substrates should form insoluble complexes
with the cyclen-thiourea receptors and afford selective separation of the desired target.
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Scheme 3.1. Structures of lactose, sucrose, APTS dye and receptor cyclen 1.

3.2 Irreversible labeling of lactose with APTS and its chemoselective separation from
lactose/sucrose mixture
Here, we report the proof of concept for the chemoselective precipitation of biological
substrates using a model system of two disaccharides: lactose and sucrose. While the physical
properties of these sugars are very similar,171 which makes their separation by common
techniques difficult,172,
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the presence of a reducing end in lactose allows a test of our

principle. 8-Aminopyrene-1,3,6-trisulfonic acid (APTS) is the dye that forms a stable
complex (Ka = 8x105 M-1) with the naphthyl thiourea cyclen receptor (cyclen 1, Scheme
3.1).9 The presence of an amino group in this dye implies that it can be readily tethered to the
reducing end of lactose via reductive amination reaction.
The combined schematic representation of chemoselective precipitation protocols is shown
on scheme 3.2.

42

lactose

lactose

sucrose

sucrose

cyclen 1

APTS

sucrose
lactose

APTS

cyclen 1

APTS

precipitation

aqueous

conjugate

aqueous

low solubility complex
aqueous
lactose

APTS
cyclen 1
precipitate

APTS

optional

CHCl3/H2O

1. hydrolysis
2. cyclen 1

extraction

lactose
cyclen 1

APTS

cyclen 1

lactose

filtration

aqueous

CHCl3

Scheme 3.2 General representation of protocols for chemoselective precipitation and isolation of lactose and
sucrose from a lactose/sucrose mixture.

First, we demonstrated that the lactose-APTS conjugate can be precipitated out from the
solution by interacting with cyclen 1 in the presence of sucrose. As detailed in the
experimental section, the reductive amination reaction between lactose and APTS was
performed according to the literature procedure174,
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and the conjugate was purified on an

anion-exchange column. Then, we developed a procedure that allows precipitation of this
conjugate through interaction with cyclen 1. The most efficient results were achieved when a
1 mM solution of lactose-APTS conjugate in H2O:MeOH (1:9) was mixed with an equal
volume of 2 mM cyclen 1 solution in the same solvent system. At these concentrations, both
lactose-APTS conjugate and cyclen 1 were completely soluble. However, the interaction
between these two components resulted in formation of a precipitate and almost complete
discoloration of the originally bright greenish solution (fig. 3.1.a). The fluorometric analysis
suggested that at least 89% of the lactose-APTS conjugate was precipitated from solution
(fig. 3.1.b).
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Figure 3.1. a) Image of 1 mM solution of APTS-lactose conjugate in the absence (left vial) and in the presence
(right vial) of 2 mM cyclen 1. Note a precipitate formed in the right vial upon application of cyclen 1; b)
Emission spectra of lactose-APTS conjugate (ex = 424 nm) before and after the treatment with cyclen 1. Top
spectrum was recorded for 1 μL of 1 mM solution of lactose-APTS conjugate in H2O:MeOH (1:9) injected into
20 mL of water. Bottom spectrum was recorded for 2 μL of the supernatant formed upon mixing of lactoseAPTS conjugate and cyclen 1 solutions, diluted into 20 mL of water.

To test the selectivity of precipitation, a sample of APTS-labeled lactose was mixed with
sucrose (1 eq.), dissolved in H2O:MeOH (1:9), followed by the addition of a solution of
cyclen 1 (2 eq.). A precipitate immediately formed, which was removed by centrifugation,
suspended in water and back-extracted with chloroform. This back-extraction led to
repartitioning of cyclen 1 into the organic layer, thereby releasing APTS-labeled lactose in
the aqueous layer. Comparison of the 1H NMR spectra (fig. 3.2) of the mixture of sucrose and
labeled lactose (spectrum 1), the supernatant following precipitation (spectrum 2) and the
back extracted aqueous solution (spectrum 3) shows the chemoselective precipitation
phenomenon. It is important to note that the precipitation and release is highly selective and
almost quantitative as evidenced by the absence of APTS signals in spectrum 2 and cyclen 1
signals in spectrum 3. The aromatic signals observed in the supernatant correspond to a partly
dissolved excess of cyclen 1. The aromatic region shows signals of APTS label with no traces
of cyclen 1. Also note the absence of acetal signal for sucrose at 5.4 ppm in this spectrum.

44

APTS

cyclen 1
sucrose

1

2

3

9.4

9.2

9.0

8.8

9.0

8.6

8.4

8.5
5.5

8.2

8.0

7.8

8.0

7.6

7.4

7.2

7.5

7.0

6.8

7.0

6.6

6.4

6.2

6.5

6.0

5.8

5.6

6.0

5.4

5.2

Figure 3.2. 1H NMR spectra (D 2O) of 1) labeled lactose and sucrose mixture; 2) supernatant
formed upon treatment of the mixture with cyclen 1 and 3) aqueous portion of precipitate
after back-extraction with CHCl 3.

To demonstrate that lactose can be selectively removed from the sucrose-lactose mixture via
the two step labeling – precipitation protocol, we then chose to carry out labeling with
disaccharide mixture, rather than mix pre-labeled lactose with sucrose. Unfortunately,
labeling of lactose with equimolar amounts of APTS dye was too slow, and sucrose
underwent acid-catalyzed hydrolysis during this time. When a five-fold excess of APTS was
used in the reductive amination, a rapid (within 2 hours) labeling of lactose took place
without any detectable sucrose degradation. Even though the resulting mixture was more
complex than a mixture of labeled lactose and sucrose, the additional component in this
mixture was APTS dye, which was also a target substrate for cyclen 1. Application of twofold excess of cyclen 1 (with respect to the total amount of APTS) resulted in a complete
removal of APTS and APTS-lactose conjugate, leaving sucrose as the only soluble
component in this mixture (fig. 3.3). Almost 70% of sucrose was recovered.
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Figure 3.3. 1H NMR spectra (D2O) of 1) APTS, lactose, sucrose and NaBH3CN mixture prior to the reductive
amination reaction; 2) same mixture after two hours of the reduction; 3) same mixture after treatment with cyclen
1. Please note disappearance of all peaks except those produced by sucrose; 4) sucrose; 5) lactose.

3.3 Reversible labeling of lactose with APTS and recovery of all the components used
for the chemoselective precipitation
The protocol for chemoselective precipitation that relies on the reductive amination reaction
leads to the irreversible labeling of the target molecule. Formation of an imine bond from the
same carbonyl group and the amino group of the dye would introduce the label that could be
hydrolyzed back to the original substrate after chemoselective precipitation. This Schiff-base
chemistry has been recently used for the reversible attachment of proteins to the solid
matrix.176 In order to test such possibility we have developed an additional protocol to label
lactose with APTS via an imine tether. Due to the reversibility of imine bond formation, the
labeling of carbonyl compounds is an equilibrium process, and an excess of the amino
compound is required in order to label most of the substrate. Even though such an approach
results in a mixture comprising at least three components (free excess label, a conjugate and
label-free substrate), our new protocol solves the problem of irreversible modification.
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First, a mixture of lactose and APTS dye was dissolved in a small volume of 1 M solution of
acetic acid and stirred for 12 hours, producing lactose-APTS imine conjugate and excess of
free dye, as evidenced by 1H NMR. Then, an excess of cyclen 1 was applied to this solution,
causing precipitation of labeled lactose and lactose-free dye. This precipitate was collected
and subjected to hydrolysis with a large volume (3 mL) of 2 M aqueous acetic acid. Under
such conditions, the precipitate was immediately dissolved. After 2 hours of stirring, the
solvent was removed under vacuum, and 1 mL of 1 N aqueous ammonia was added to the
solid residue and back extracted with chloroform. The 1H NMR analysis of organic and
aqueous layers showed that only cyclen 1 was present in chloroform, and a mixture of lactose
and APTS were found in the aqueous layer. Finally, lactose was separated from the APTS
dye by the second application of cyclen 1, which resulted in precipitation of cyclen 1 and
APTS dye, and left lactose as the only component in aqueous layer. Resuspension of the
precipitate in water and back extraction with chloroform separated cyclen 1 from APTS (fig.
3.4)
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Figure 3.4. 1H NMR spectra of 1) reaction mixture comprising lactose and APTS dye in D 2O; 2) recovered
lactose in D2O; 3) recovered APTS dye in D2O and 4) recovered cyclen 1 in DMSO-d6.

With this new protocol, not only could lactose be isolated in an unaltered form, but the dye
and cyclen 1 were recovered as well.
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An attempt of separation of lactose from sucrose in an unmodified form reached only partial
success. While the isolated precipitate gave pure lactose after hydrolysis and back extraction,
the supernatant showed sucrose contaminated with some residual lactose. Apparently,
precipitation of lactose was not complete because of the reversible nature of the imine bond,
which set the equilibrium between labeled and label-free disaccharide. Although the
methodology of separation that relies on the temporary labeling via imine bond did not allow
us to separate both sugars in the pure form, it can still be used for isolation of reducing
sugars. In case if non-reducing sugars are the target substrates, they can be separated from the
reducing components via permanent labeling of the latter via amine bond.
Since many sugars possess reducing ends, a similar methodology can be applied to their
separation. One example of practical value is the separation of low molecular weight
heparin177. Heparin oligomers contain reducing ends178 and therefore can be labeled with
APTS dye and complexed with cyclen 1. The overall solubility of such complexes should
depend on the length of the heparin oligomers, where the complexes of the shortest oligomers
will be the least soluble and the complexes of the longest oligomers will be the most soluble.
Our preliminary studies indicated that labeling of a heparin digest with APTS, followed by
the treatment with cyclen 1 resulted in a partial precipitation of heparin conjugates, the extent
of which was dependent on the solvent composition. Chemoselective precipitation of heparin
oligomers will be the focus of our future studies.

3.4 Conclusions
We developed a facile method for separation of biomolecules via tethering them to the APTS
dye and subsequently applying to these conjugates a synthetic receptor cylen 1, which binds
to the APTS label. Due to the low solubility of the APTS-cyclen 1 complex, the APTS
conjugate precipitates out from the solution upon interaction with cyclen 1, thus leaving
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unlabeled molecules as the only soluble components in the mixture. Whereas tethering of
carbonyl-containing compounds to APTS via the reductive amination reaction makes them
permanently labeled with APTS, the attachment of APTS through an imine bond allows for
release of the precipitated molecule in the label-free form. Subsequent extraction of
supernatant with organic solvent provides a means for the recovery of all components used
for the chemoselective precipitation. This feature makes our new approach especially
attractive for the large-scale separations of biological molecules. Separation of low molecular
weight heparin oligomers is the focus of our future studies.
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Chapter 4
Immobilization of cyclen based receptors for pyrene dyes on solid supports:
Beginning of a new affinity chromatography technique
4.1. Introduction
The successful use of dye-receptor pair in chemoslective precipitation of lactose from
sucrose10 encouraged us to further explore the use of this dye-receptor pair in separations
technology. In order to broaden the scope of this dye-receptor pair in separations technology,
we decided to use this pair in affinity chromatography. We hypothesized that if a receptor
having a functional group on the cyclen core can be synthesized, then this receptor can be
immobilized on a solid support using this functional group. The receptor for pyrene dyes,
immobilized on the solid support will be used as selection auxiliary for affinity
chromatography. We expected that the substrates conjugated with the pyrene dyes will
exhibit elongated retention times due to the specific interactions of the label with the solid
support. This approach might prove itself as valuable means for purification of biological
substrates, since the pyrene labels are commonly used in biotechnology for marking the
targets of interest.179, 180
4.2 Synthesis of p-NO2-Bn-Cyclen (core cyclen 9a)
A functionalized receptor was required for the immobilization of the receptor on the affinity
matrix. The p-NO2-Bn-Cyclen (core cyclen 9a), which has nitro benzyl group attached to the
cyclen core can be used for the synthesis of functionalized receptor. Reduction of nitro group
to an amine group will provide a reactive group which can be used for the immobilization of
the receptor on various affinity supports. Although, this reagent was commercially available,
we decided to synthesize it because of its high cost. Synthesis of p-NO2-Bn-Cyclen (core
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cyclen 9a) had been reported by Oliver Renn et. al.191 They synthesized it according to
scheme 4.1.

Scheme 4.1. Reaction scheme for the large scale synthesis of p-NO2-Bn-Cyclen (core cyclen 9a) from
nitrophenylalanine
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In this scheme a number of intermediates e.g. compound F, G and H (p-NO2-Bn-Cyclen),
required HPLC purification making it an expensive process. We significantly modified this
scheme and successfully developed conditions where normal chromatography can be used for
the purification of the compound F and G. In the last step of the synthesis where detosylation
was done to synthesize compound H (p-NO2-Bn-Cyclen), barium hydroxide was used to
neutralize the excess sulfuric acid. Barium hydroxide is a very corrosive compound and can
cause severe burns. We replaced it with less harmful potassium carbonate. A lot of solid was
generated when potassium carbonate was added to the reaction mixture. This solid was stirred
with chloroform to extract the compound H (p-NO2-Bn-Cyclen) from the solid. Thus, we
successfully developed an extraction procedure for the isolation of final product instead of
reverse phase HPLC purification as used in the literature. These changes in the synthetic
procedure significantly reduced the cost of production of p-NO2-Bn-Cyclen (core cyclen 9a).
4.3. Synthesis of functionalized receptor
Functionalized cyclen receptor 11 was synthesized according to the scheme 4.2. 9 It was the
same scheme used for the synthesis of the receptors 4-8 (see chapter 2), except that p-NO2Bn-Cyclen (core cyclen 9a) was used instead of cyclen. The synthesis started with the
recognition arm (step a), followed by its attachment to the core cyclen 9a (step b) to furnish
the precursor 9, which was then deprotected under acidic conditions (step c) and reacted with
4-methoxyphenyl isocynate to yield functionalized OMe receptor 10 (step d).

52

Scheme 4.2: a) Bromoacetyl bromide, Et3N, CH2Cl2, rt, 5 hrs, 90%; b) functionalized cyclen, anhydrous
DMF, K2CO3, First 6 hrs 600C followed by rt overnight, 55% ; c) TFA/CH2Cl2, rt, 6 hrs; d) 4-methoxyphenyl
isocyanate, isopropanol/CH3CN, Et3N, rt, 16hrs, 40%. Overall yield: 22% in core cyclen 9a conversion.

The core cyclen 9a is an expensive compound and it was involved in the second step of the
synthesis, followed by two more steps before the functionalized receptor 10 was obtained. As
a result, even though the reasonable yields were acquired for the last three steps, the overall
conversion of cyclen 9a was unacceptably low.
Therefore, we decided to use an alternative scheme (scheme 4.3) which involved the use of
cyclen 9a only in the final step of the receptor synthesis. This alternative synthesis started
with the addition of 4-methoxyphenyl isocynate to ethanolamine (step a) to yield a partial
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arm 10a in almost 100% yield. It was then reacted with bromoacetyl bromide to furnish a
complete arm 10b in 90% yield. The “complete arm” 10b was then attached to the core
cyclen 9a to afford functionalized OMe receptor 10 in a 62% with respect to the core cyclen
9a conversion. This was almost threefold increase in the procedure efficiency, comparing to
the original route outlined in the scheme 4.2. Several reaction conditions such as use of
different bases (organic and inorganic), different solvents, different reaction times and
different temperatures were tried to optimize the yield. The best results were obtained when
the step c was carried out in dry DMF at room temperature for six hours in the presence of
K2CO3.
Additionally, new synthetic route has not only increased the yield but it also simplified the
overall procedure, as no purification was needed in the first step and the partial arm 10a was
used as such in the step b for the synthesis of complete arm 10b.
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Scheme 4.3. Synthesis of the receptor 11. a) ethyl acetate, rt, 1hr, 97%; b) bromoacetyl bromide, Et 3N, CH2Cl2, rt, 5
hrs, 90%; c) anhydrous DMF, Na2CO3, rt, 6 hrs, 62%; d) anhydrous THF, Sn/HCl(g), rt, 4hrs, 63%.

The nitro group of functionalized OMe receptor 10 was then reduced to yield the final
functionalized OMe receptor 11. Several attempts to reduce the nitro group with reduction
procedures such as Na2S2O4, Ni/H2, Co/H2, NaBH4, Ni/H2 in the presence of NaBH4 have
either failed or gave unacceptably low yields on the target compound. Finally, the Sn/HCl (g)
reagent was used for the reduction. The drawback of this reagent was in the fact that each arm
of the receptor had an ester linker susceptible to the acidic hydrolysis in the presence of
moisture. However, by choosing proper conditions and apparatus design, we were able to
successfully reduce the nitro group in a 63% yield (scheme 4.3).
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4.4 Immobilization of functionalized receptor on solid support
Selection of solid support is a very important consideration in affinity systems. To be an
adequate support, the matrix should be functionalized (so that the receptor can be
immobilized using these functional groups), it should not show any significant nonspecific
interactions neither with the target substrate nor with the receptor. The receptor is positively
charged due to the cyclen core and the dye has negative charge due to the sulfonate groups.
Thus, a neutral resin would be the most suitable support for immobilization, as it diminishes
the nonspecific interactions between both the resin and the dye, as well as the resin and the
receptor. Prior to the immobilization of the receptor, a series of fluorometric experiments of
the matrix were carried out to ascertain the suitability of the given matrix for the affinity
chromatography. In a typical experiment, emission spectra were recorded for a 50nM HPTS
solution in the presence of the resin and (or) receptor at an excitation wavelength of 405 nm.
Benzaloxy benzaldehyde resin has an aldehyde group which can be used for the
immobilization of the receptor 11 by the reductive amination. However, fluorometric
experiments (fig. 4.1.A) showed unacceptable interactions with the HPTS dye.

The

fluorescence intensity of HPTS solution decreased proportionally to the amount of resin
added to the fluorometric cell (fig 4.1.A, traces 1 and 2 from the bottom). This could be due
to the π-π stacking of the aromatic groups of the resin with the aromatic core of the HPTS.
Therefore, it was not used for immobilization of the functionalized receptor.
Benzenesulfonyl chloride resin has reactive sulfonyl chloride groups which can react with the
receptor 11 to form a sulfonamide bond. However, fluorometric experiments (fig. 4.1.B)
showed undesirable interactions of the resin with the receptor. Whereas little change in
fluorescence of HPTS was observed in the presence of the resin alone (fig 4.1.B, traces 2 and
3 from the bottom), a significant increase in fluorescence was observed in the presence of
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receptor 11 and the resin (fig 4.1.B, trace 4 from the bottom). This was opposite to the effect
produced by the receptor 11 on the fluorescence of HPTS in the absence of the resin (fig
4.1.B, trace 1 from the bottom), where almost complete fluorescence quenching was
observed. These results strongly suggest that the resin was interacting either with receptor 11
or with the receptor 11-HPTS complex. In both cases, this made the sulfonyl chloride resin
unsuitable for our purposes. The observed results with the sulfonyl chloride resin can be
rationalized in the following way: Once placed under physiological conditions, the sulfonyl
chloride groups were likely hydrolyzed to produce anionic sulfonic acid residues. While the
anionic nature of the resin ensured the lack of interactions with the anionic HPTS dye, the
cationic receptor 11 interacted with the resin via either electrostatic or electrostatic and π-π
stacking interactions. Therefore, this resin was not used for immobilization of the receptor 11.
Next, we decided to look at the epoxy-functionalized resin, which can be used for
immobilization of receptor 11 via nucleophilic ring opening. The hydroxide groups, formed
upon the ring opening are neutral under physiological conditions, which is an ideal case for
the lack of undesirable interactions between the resin and the dye or receptor. Indeed, no
significant change in fluorescence was observed for the solution of HPTS in the presence of
the resin (fig. 4.1.C, traces 3 and 4 from the bottom), whereas the fluorescence quenching by
receptor 11 was almost identical in the presence and in the absence of the resin. A small
increase in the fluorescence intensity in the presence of the resin can be explained by the light
scattering caused by relatively large resin beads. We concluded that the epoxy resin could
potentially serve as a solid support for immobilization of receptor 11.
Dowex Mac-3 ion exchange resin has carboxylic acid functional groups which can be used to
attach receptor 11 by forming an amide bond. Due to the inherent anionic nature, this resin
was not expected to interact with HPTS dye. The fluorometric experiments for this resin (fig.
4.1.D) showed the results very similar to those observed for the epoxy resin: the Dowex Mac57

3 alone produced little effect on the fluorescence of HPTS dye (fig. 4.1.D, traces 3 and 4
from the bottom), whereas the quenching efficiency of receptor 11 was not altered by the
addition of the resin to a significant extent (fig. 4.1.D, traces 1 and 2 from the bottom),
suggesting that the resin did not interact with either the dye or receptor 11.
Both the epoxy- and Dowex Mac-3 resins were potentially suitable for use as solid supports,
however, several attempts to immobilize the receptor 11 on these resins failed. We concluded
that relatively less reactive functional groups on the resins, heterogeneous reaction
conditions, less reactive aromatic amine group of the receptor and steric hindrance could be
the factors causing problems in the immobilization step.

A
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Figure 4.1. Raw fluorescence data for 50 nM solution of HPTS in the presence of the resins and (or) receptor
11. The excitation wavelength was set at 405 nm in all experiments. A) Benzoyloxy benzaldehyde resin; B)
Sulfonyl chloride resin; C) Epoxy resin; D) Carboxylic acid (Dowex Mac-3) resin.

4.5 Synthesis of functionalized receptor with a spacer arm
In order to overcome the above mentioned problems likely arising from the steric hindrance
at the surface of the resins, we decided to attach a spacer arm to the aromatic amine of the
receptor which would have a primary amine on the free end. Such a modification of receptor
11 was expected to benefit the coupling reaction in a dual way: first, this spacer was expected
to reduce the crowdedness around the reactive moiety; second, the less nucleophilic aromatic
amino group would be conceptually substituted for the much more nucleophilic primary
aliphatic amino group.
The spacer arm was attached by a two step synthesis (scheme 4.4.2.) In the first step, receptor
11 was reacted with succinic anhydride to give compound 12 in 80% yield. It was then
reacted

with

N-Boc-1,3-propanediamine

in

the

presence

of

1-Ethyl-3-(3-

dimethyaminopropyl)carbodiimide (EDC) and catalytic amount of DMAP (15 mol%) to
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afford receptor 13 in 60% yield. N-Boc-1,3-propanediamine was synthesized by mono boc
protection of propylene diamine according to scheme 4.4.1.

Scheme 4.4.1. Synthesis of N-Boc-1,3-propanediamine. a) Boc anhydride, rt, 6 hrs. Scheme 4.4.2. Synthesis of
receptor 13. a) Succinic anhydride, THF/CH3CN, rt, 12 hrs, 80%; b) N-Boc-1,3-propanediamine, EDC, DMAP, DMF,
rt, 18 hrs.

4.6 Immobilization of the receptor 13
Receptor 13 was deprotected and subjected to immobilization reaction on the acid and epoxy
functionalized resins. However, all these attempts to immobilize the receptor failed.
In addition to the resins discussed above, other functionalized solid supports are
commercially available. One such support was NHS activated agarose, which was also
potentially suitable for the coupling with the receptors 11 or 13. First, we selected less
nucleophilic and more sterically crowded receptor 11 for the immobilization, as the more
cost-efficient precursor among these two. Immobilization was attempted according to scheme
4.5 and the reaction was monitored by thin layer chromatography (TLC). TLC showed
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formation of one new spot and disappearance of the starting receptor from the reaction
mixture. This new spot was due to the formation of N-hydroxysuccinimide. TLC analysis
indicated that the reaction was complete in 16 hours

Scheme 4.5. Immobilization of receptor 11 on NHS activated agarose. TLC of reaction mixture at various intervals of times
as visualized under UV lamp. Spot on far left, reaction at time T=0, Middle spot a co spot of reaction mixtur at time T=0 and
time T=16 hrs, Spot on far right, reaction at time T=16 hrs.

4.7 Fluorometric titrations of receptor 11 immobilized on the solid support
We successfully immobilized the receptor 11 on the solid support. A series of fluorometric
experiments (fig. 4.2) were performed in order to ascertain the effectiveness of this new
affinity chromatography matrix. As discussed above, the unmodified resin produced little
effect on the fluorescence of HPTS dye (fig. 4.2, traces 3 and 4 from the bottom). In contrast,
the resin with immobilized receptor 11 caused almost complete fluorescence quenching upon
addition to the solution of HPTS. The fluorescence quenching caused by the immobilized
receptor 11 was even stronger than the fluorescence quenching caused by the same amount of
the resin-free receptor 11 (traces 2 and 1 from the bottom, respectively). The residual
fluorescence of HPTS in the presence of resin-free receptor 11 was due to the intrinsic
fluorescence of receptor 11-HPTS complex. Although low, this fluorescence has measurable
intensity and is detectable regardless of the amount of the receptor added to the solution.
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Unlike with the resin-free receptor 11, the immobilized receptor caused a specific adsorption
of the dye on the surface of the resin, thus providing its removal from the solution, which was
consistent with the complete loss of fluorescence.
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Figure 4.2. Raw fluorescence data for 50 nM solution of HPTS in the presence of the resin and (or) free or
immobilized receptor 11. The excitation wavelength was set at 405 nm in all experiments.

4.8 Conclusions
We successfully synthesized cyclen receptors 11 and 13, suitable for immobilization on the
solid support for the production of the affinity chromatography matrices. We reported two
different routes for the synthesis of receptor 11 while developing a simpler and more
productive scheme 4.3. We reported a 2.8 fold increase in the yield by using this alternative
scheme for the synthesis of receptor 10. We have analyzed several different resins for their
suitability as solid supports, and we identified NHS-activated agarose as the most appropriate
candidate for these purposes. We successfully immobilized receptor 11 on NHS-activated
agarose via amide coupling. The affinity matrix obtained showed specific affinity towards
HPTS dye in the fluorometric experiments, which makes it suitable for the separation of
HPTS-labeled biological substrates.
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Chapter 5
Future Work
5.1 Introduction
We successfully immobilized receptor 11 on NHS activated agarose. Initial results from
fluorometric experiments indicated that the affinity support was very effective and a
fluorescence quenching up to 95% was observed. The applicability of this matrix for the
separation of various systems will be studied.
5.2 Separation of a mixture of dyes
We designed this affinity support for the separation of substrates conjugated with the pyrenebased dyes (HPTS, APTS, PTA etc) (fig. 1.3). First, we will check the efficiency of the
affinity matrix for the separation of the mixture of the dyes, where one dye will be a pyrenebased dye, and the other dyes will have a different nature. Anionic fluorescein-based dyes
will be added to the mixture to assess the specificity of the affinity matrix, cationic dyes, such
as safranin O181 will be used as a negative control. The resolving efficiency of the affinity
matrix will be quantified through the ratios of the retention times for the pyrene-based dyes
and their nonbinding counterparts. The elution profiles and the holding capacity of the matrix
will be assessed as well.
5.3 Separation of low molecular weight heparin (LMWH)

Figure 5.1 Major repeating disaccharide of heparin
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Heparin is a linear polysaccharide consisting of uronic acid-(1→4)-D-glucosamine repeating
disaccharide subunits (fig. 5.1) having a high degree of sulfation and acetylation.182 Heparin
is used as an anticoagulant. Unfractionated heparin is a heterogeneous mixture of
polysaccharide chains ranging in molecular weight from 3000 to 30,000. LMWH are
produced by controlled enzymatic or chemical depolymerization (scheme 5.1) of
unfractionated or large molecular weight heparins, followed by size and affinity separation.183
They have an average molecular weight of about 5000. Both unfractionated and LMWH are
effective antithrombic therapeutics, but frequent use of unfractionated heparins can cause
thrombocytopenia.184 In contrast, LMWH are found safer to use. Also, outpatient treatment of
conditions such as deep vein thrombosis and pulmonary embolism is possible with LMWH
compared to necessary hospitalization as needed for treatment with unfractionated heparins.
Therefore, use of LMWH is both safe and financially beneficial. Hence, a simple method for
separation of LMWH will be of great practical interest.

Scheme 5.1. a) acid catalyzed b) enzymatic depolymerization of heparin

Since chemical and enzymatic depolymerization produce fragments having single reducing
ends, APTS can be coupled with these fragments by reductive amination. These labeled
fragments can be then purified using receptor immobilized affinity supports. The
immobilization of receptor 11 was performed in DMF/H2O solvent system; once all the
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receptor is immobilized, remaining NHS-ester groups will be hydrolyzed and carboxylic acid
groups will be produced. The carboxylic acid groups produced are negatively charged and
heparin itself is negatively charged due to the sulfate groups. As a result, both resin and
heparin will repel each other. This repulsion will be more pronounced between the large
heparin fragment and the resin and hence a differential binding will be achieved. The larger
the pyrene conjugated heparin fragment is, the weaker binding to the affinity support will be
expected. This variable binding affinity will be used to develop specific elution protocols for
the effective separation of LMWH.
5.4 Mapping of cells expressing ligand-gated ion channels
Ligand-gated ion channels are a group of transmembrane proteins. These have specific
binding sites for ligands, such as neurotransmitters.185 Once bound to the ligand the ion
channel opens up and influx or efflux of ions occurs which in turn plays an important role in
many physiological processes. These ligand-gated ion channels are related to various diseases
such as schizophrenia, depression, attention deficit, hyperactivity disorder, Alzheimer’s
disease and of course, tobacco addiction.186-189Thus, location of these ligand-gated ion
channels and study of mechanism of ion transport is of great significance in finding a cure for
these diseases.
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Figure 5.2. Structure of receptor 12.

We have synthesized receptor 12 (fig. 5.2) which bears a carboxylic group attached to
the cyclen core. This receptor will be reacted with 1,2-dioleoyl-sn-glycero-3phosphoethanolamine (DOPE) to produce a modified lipid bearing a receptor
molecule. This lipid will be then incorporated into the liposomes filled with the
reporter dye. Several neurotransmitters such as acetylcholine, nicotine, GABA etc
have been identified as ligands for the receptors on the ligand-gated ion channels.
These ligands will be coupled with the pyrene based dyes. The effectiveness of these
dye conjugated ligands will be determined by adding these into the cells bearing
ligand-gated ion channels. If the dye-ligand conjugate shows effective binding then
the suspension of liposomes bearing a surface-anchored receptor will be added to
these cells. The receptor will bind to the pyrene portion of the ligand conjugate which
in turn attaches the liposome to the ligand-gated ion channels. Since liposomes will
be filled with the reporter dye, a single receptor on ligand-gated ion channels can be
detected by this fluorescence amplification.
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Scheme 5.2. A general scheme for the detection of ligand-gated ion channels

This work has opened several new venues and applicability of this dye-receptor pair in the
fields of biochemistry, pharmacology, cell biology etc. will be explored.
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Experimental Section
General Methods:
All the chemicals and solvents were purchased from Sigma-Aldrich (Milwaukee, WI), Acros
Organics or Fisher Scientific (Pittsburgh, PA) and used without further purification. The
column chromatographic separations were performed with silica gel 60 (230-400 mesh). All
1

H NMR and

13

C NMR spectra were recorded on Varian 300 and 400 MHz NMR

spectrometers. All NMR chemical shifts (δ) were reported in parts per million (ppm) and
were determined relative to the standard values for deuterated solvents. Electro spray
ionization mass spectroscopy (ESI-MS) analysis was carried out using a Q-TOF2 from
Micromass (Manchester, U.K.). All spectrophotometric experiments were carried out on a
Fluoromax 3 (Jobin-Yvon/Horiba) spectrophotometer.
Bromoacetic Acid 2-t-Butoxycarbonylaminoethyl Ester (i). tert-Butyl-N-(2-hydroxy ethyl)
carbamate (4.5 g, 28 mmol) was dissolved in dichloromethane (30 mL), and triethylamine
(3.9 mL, 28 mmol) was added. The mixture was stirred for 10 min at room temperature, and
bromoacetyl bromide (3.15 mL, 36 mmol) was added dropwise within 5 min. The reaction
mixture was stirred for 5 h at room temperature, the solvent was removed under reduced
pressure, and the crude solid was purified by column chromatography (silica gel,
CH2Cl2/EtOAc 4:6) to give 7.0 g of i (25 mmol, 90%). 1H NMR (300 MHz, DMSO) δ 7.03 –
6.91 (q, J = 6.0, 5.4 Hz, 1H), 4.22 – 4.03 (m, 4H), 3.26 – 3.12 (p, J = 5.4 Hz, 2H), 1.50 – 1.35
(d, J = 4.1 Hz, 9H). ESI-MS calcd for C9H16BrNO4Na (M+Na+), 304.02; found 304.02.
tetrakis(2-((tert-butoxycarbonyl)amino)ethyl)2,2',2'',2'''-(1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (cyclen NH-Boc) (ii). Cyclen (0.4 g,
2.3 mmol), sodium carbonate (2.19 g, 20.7 mmol), and bromoacetic acid 2tertbutoxycarbonylamino ethyl ester (3.8 g, 13.8 mmol) were suspended in 20 mL of
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acetonitrile. The reaction mixture was stirred for 72 h at room temperature, and the solvent
was removed under reduced pressure. The solid residue was purified by column
chromatography (silica gel, CH3OH/CHCl3 5:95) to afford 1.28 g of cyclen NH-Boc ii (1.3
mmol, 56%). 1H NMR (400 MHz, DMSO) δ 6.97 – 6.89 (t, J = 5.8 Hz, 1H), 4.09 – 4.04 (s,
2H), 3.22 – 3.14 (m, 3H), 1.41 – 1.33 (d, J = 6.8 Hz, 10H). ESI-MS calcd for C44H81BrN8O16
(M+H+), 977.57, and for C44H80BrN8O16Na (M+Na+), 999.56; found 977.57 and 999.55.
tetrakis(2-(3-(4-nitrophenyl)thioureido)ethyl)2,2',2'',2'''-(1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (4). The precursor ii (25 mg, 0.025
mmol) was dissolved in 1 mL of CH2Cl2, and trifluoroacetic acid (0.19 mL of 50% v/v
solution in CH2Cl2) was added dropwise. The reaction mixture was stirred for 6 h at room
temperature, and the solvent and excess of trifluoroacetic acid were removed under reduced
pressure to afford crude deprotected cyclen tertrafluoroacetate. Deprotected cyclen was
reacted without further purification. The crude was dissolved in 1 mL of dry THF and pnitrophenyl isothiocynate (48 mg, 0.266 mmol) was added to this solution. After 15 minutes,
triethylamine was added slowly to bring the pH to 9. Reaction was stirred at room
temperature for 6 hours and then evaporated to dryness under reduced pressure. The crude
was purified by column chromatography (silica gel, 2-6% MeOH in CHCl3) to afford 27.5
mg (0.021mmol, 82%) of receptor 4. 1H NMR (400 MHz, DMSO) δ 8.27 – 8.10 (m, 8H),
7.94 – 7.79 (m, 8H), 4.35 – 4.28 (d, J = 8.5 Hz, 8H), 3.83 – 3.78 (s, 8H), 3.22 – 3.13 (dd, J =
5.2, 1.0 Hz, 4H). ESI-MS calcd for C52H65N16O16S4 (M+H+), 1297.36; found 1297.35.
tetrakis(2-(3-(4-methoxyphenyl)thioureido)ethyl) 2,2',2'',2'''-(1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (5). This compound was synthesized
from cyclen NH-Boc ii (25 mg, 0.025 mmol) and 4-Methoxyphenyl isothiocyanate (0.041 ml,
0.297 mmol) in dry THF according to the procedure described for the synthesis of receptor 4.
The isolated yield of receptor 5 was 12.3 mg (0.01 mmol, 40%). 1H NMR (300 MHz,
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DMSO) δ 7.27 – 7.17 (d, J = 8.4 Hz, 8H), 6.94 – 6.84 (d, J = 8.4 Hz, 8H), 4.27 – 4.20 (s, 8H),
3.77 – 3.70 (d, J = 0.6 Hz, 12H), 2.56 – 2.40 (d, J = 1.6 Hz, 6H), 2.12 – 2.06 (d, J = 0.6 Hz,
8H), 1.30 – 1.21 (d, J = 8.7 Hz, 1H). ESI-MS calcd for C56H76N12O12S4Na (M+Na+),
1259.46; found 1259.51.
tetrakis(2-(3-(4-bromophenyl)thioureido)ethyl)2,2',2'',2'''-(1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (6). This compound was synthesized
from cyclen NH-Boc ii (25 mg, 0.025 mmol) and 4-Bromophenyl isothiocynate (70 mg, 0.3
mmol) in isopropyl alcohol according to the procedure described for the synthesis of receptor
4. The isolated yield of the receptor 6 was 25.2 mg (0.017 mmol, 68.6%). 1H NMR (300
MHz, DMSO) δ 9.92 – 9.76 (s, 4H), 8.06 – 8.00 (s, 4H), 7.60 – 7.30 (m, 15H), 4.32 – 4.21 (d,
J = 6.0 Hz, 8H), 3.81 – 3.74 (s, 8H), 2.61 – 2.42 (m, 8H). ESI-MS calcd for
C52H66Br4N12O8S4 (M+H+), 1429.06; found 1429.05.
tetrakis(2-(3-butylthioureido)ethyl)2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10tetrayl)tetraacetate (7). This compound was synthesized from cyclen NH-Boc ii (25 mg,
0.025 mmol) and Butyl isothiocynate (0.041 ml, 1.3 mmol) in isopropyl alcohol according to
the procedure described for the synthesis of receptor 4. The isolated yield of receptor 7 was
0.0057 mmol, 23%. 1H NMR (300 MHz, DMSO) δ 9.32 – 9.25 (s, 4H), 8.37 – 8.29, 4.27 –
4.15 (t, J = 7.5 Hz, 8H), 3.57 – 3.44 (dd, J = 7.8, 7.2 Hz, 8H), 3.43 – 3.27 (m, 11H), 2.19 –
2.03 (m, 14H), 1.66 – 1.49 (m, 8H), 1.40 – 1.17 (m, 9H), 0.96 – 0.84 (t, J = 7.3 Hz, 13H).
ESI-MS calcd for C44H85N12O8S4 (M+H+), 1037.54; found 1037.35.
tetrakis(2-benzamidoethyl)2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10tetrayl)tetraacetate (8). This compound was synthesized from cyclen NH-Boc ii (25 mg,
0.025 mmol) and Benzoyl chloride (0.046 ml, 0.39 mmol) in isopropyl dichloromethane
according to the procedure described for the synthesis of receptor 4. The isolated yield of
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receptor 8 was 0.018 mmol, 74%. 1H NMR (400 MHz, CDCl3) δ 7.95 – 7.81 (m, 7H), 7.53 –
7.32 (m, 12H), 7.29 – 7.16 (d, J = 0.7 Hz, 5H), 4.34 – 4.24 (q, J = 6.3, 5.0 Hz, 6H), 3.71 –
3.64 (m, 8H), 3.55 – 3.50 (s, 6H), 2.90 – 2.78 (d, J = 9.5 Hz, 13H). ESI-MS calcd for
C52H65N8O12 (M+H+), 993.56; found 993.56.
Fluorometric titration of HPTS with receptors 4-8. In a typical experiment, an aqueous
solution (2 mL) containing 50 nM HPTS, 100 mM NaCl, 10 mM NaxH3-xPO4 (x = 1, 2; pH
6.4) was placed in a thermostated spectrophotometric cell set at 250C. The solution was
gently stirred during the experiment. Prior to the spectrometric recording, 20μL of 25-5000
μM solution of receptors 4-8 in DMSO were added to the cell giving the final concentration
of the receptors in the range of 2.5-500 μM. The emission spectra were then recorded with
the excitation wavelength of 405 nm. The emission maxima at 510 nm were monitored.
Binding constant and the maximum emission loss with the confidence interval values were
then computed using the homemade nonlinear regression curve fitting program.
Labeling of lactose with APTS dye via reductive amination.

8-Aminopyrene-1,3,6-

trisulfonic acid trisodium salt (APTS) (4.8 mg, 0.009 mmol) and lactose (50.6 mg, 0.140
mmol, 15 fold excess) were dissolved in 3mL of 15% aqueous acetic acid, sodium
cyanoborohydide (80 mg, 1.28 mmol, 142 fold excess) was added and reaction was refluxed
at 70 oC for 5 days. The reaction was purified by ion exchange chromatography ( DEAE
Sephadex A-2S anion exchange resin, 1% HCl eluent). A sample of labeled lactose (3 mg,
0.0037 mmol) was mixed with sucrose (1.3 mg, 0.0037 mmol, 1 eq) and used in the further
chemoselective precipitation experiment.
Labeled lactose 1H NMR (300 MHz, D2O) δ 9.14 (s, 1H), 9.11 (d, 1H, J=8.9 Hz), 9.02 (d,
1H, J=11.9 Hz), 8.92 (d, 1H, J=8.9 Hz), 8.51 (d, 1H, J=8.9 Hz), 8.35 (s, 1H), 4.09-3.63 (m,
13H). MS (ESI [M]-), monosodium salt: 804.27, calcd for C28H31NNaO19S3: 804.06.
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Labeled lactose + sucrose 1H NMR (300 MHz, D2O) δ 9.16 (s, 1H), 9.13 (d, 1H, J=8.9 Hz),
9.07 (d, 1H, J=11.9 Hz), 8.98 (d, 1H, J=8.9 Hz), 8.51 (d, 1H, J=8.9 Hz), 8.44 (s, 1H), 5.40 (d,
1H, J=2.9 Hz), 4.20 (d, 1H, J=8.9 Hz), 4.04 (t, 1H, J=8.9 Hz), 3.90-3.15 (m, 23H).

Precipitation of labeled lactose. A solution of lactose-APTS conjugate (1 mM) in
H2O:MeOH (1:9) was mixed with equal volume of 2 mM solution of cyclen 1 in the same
solvent system. An immediate precipitate formation was observed. The resulting solution was
centrifuged for 15 minutes (14,000 rpm). The supernatant was removed, the precipitate was
suspended in water, and extracted with chloroform. The extraction caused partitioning of
lactose-APTS conjugate into the aqueous layer and partitioning of cyclen 1 into the organic
layer.
Supernatant 1H NMR (300 MHZ, D2O) δ 5.40 (d, 1H, J=2.9 Hz), 4.20 (d, 1H, J=8.9 Hz),
4.04 (t, 1H, J=8.9 Hz), 3.90-3.15 (m, 11H).
Aqueous layer (after back extraction) 1H NMR (300 MHz, D2O) δ 9.10 (s, 1H), 9.05 (d, 1H,
J=8.9 Hz), 8.92 (d, 1H, J=11.9 Hz), 8.80 (d, 1H, J=8.9 Hz), 8.54 (d, 1H, J=11.9 Hz), 8.42 (s,
1H), 3.80- 3.50 (m, 12H).

Labeling of lactose with APTS in the presence of sucrose via reductive amination.
Lactose (1mg, 0.0029 mmol), sucrose (1mg, 0.0029 mmol,) and 8-aminopyrene-1,3,6trisulfonic acid trisodium salt (APTS) (4.4 mg, 0.0087 mmol, 3.2 fold excess) were dissolved
in 2ml of 15% aqueous acetic acid, sodium cyanoborohydide (24 mg, 0.381 mmol, 141 fold
excess) was added and the reaction mixture was refluxed at 70 oC for 2 hours. Precipitation
of conjugate was carried out in the same manner as described in the previous section.
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T=0 hrs

1

H NMR (300 MHz, D2O) δ 9.01 (s, 1H), 8.97 (d, 1H, J=11.9 Hz), 8.85 (d, 1H,

J=8.9 Hz), 8.75 (d, 1H, J=11.9 Hz), 8.36 (d, 1H, J=8.9 Hz), 8.16 (s, 1H), 5.29 (s, 1H), 5.11
(s, 1H), 4.42 (d, 1H, J=8.9 Hz), 4.11 (d, 1H, J=8.9 Hz), 3.94 (t, 1H, J=8.9 Hz), 3.90-3.40 (m,
23H).
T=2 hrs 1H NMR (300 MHZ, D2O) δ 9.05 (s, 1H), 8.99 (d, 1H, J=8.9 Hz), 8.85 (d, 1H, J=8.9
Hz), 8.75 (d, 1H, J=11.9 Hz), 8.39 (d, 1H, J=8.9 Hz), 8.12 (s, 1H), 5.35 (d, 1H, J=2.9 Hz),
4.42 (d, 1H, J=8.9 Hz), 4.18 (d, 1H, J=8.9 Hz), 4.0 (t, 1H, J=8.9 Hz), 3.90-3.40 (m, 23H).
Supernatant 1H NMR (300 MHz, D2O) δ 5.40 (d, 1H, J=2.9 Hz), 4.20 (d, 1H, J=8.9 Hz), 4.03
(t, 1H, J=8.9 Hz), 3.90-3.40 (m, 11H).
Lactose 1H NMR (300 MHz, D2O) δ 5.19 (d, 1H, J=5.9 Hz), 4.42 (d, 1H, J=5.9 Hz), 3.963.48 (m, 12H).
Sucrose 1H NMR (300 MHz, D2O) δ 5.38 (d, 1H, J=2.9 Hz), 4.19 (d, 1H, J=8.9 Hz), 4.02 (t,
1H, J=8.9 Hz), 3.90-3.40 (m, 11H)

Labeling of lactose with APTS dye via imine bond. A mixture of lactose (2 mg, 0.0058
mmol) and APTS (2.7 mg, 0.0114 mmol) was dissolved in the minimum amount of 10%
aqueous acetic acid (0.2 mL). The reaction mixture was stirred for 12 hrs at 70 0C. Then the
reaction mixture was cooled to the room temperature, the solvent was removed under reduced
pressure, and 1H NMR for the solid residue was recorded in D2O. The 1H NMR spectrum
showed some conjugated as well as some free APTS present in the reaction mixture.
Precipitation of lactose-APTS imine conjugate. The reaction mixture described in the
previous section was dissolved in 0.2 mL of 80% aqueous methanol. A saturated solution of
cyclen 1 in 1 mL of the same solvent was prepared. Approximately 10 mg of cyclen 1 was
dissolved. This saturated solution of cyclen 1 was added to the solution of lactose-APTS
imine conjugate in small aliquotes. Instantaneous precipitation was observed. The solution of
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cyclen 1 was added until green fluorescence of reaction mixture disappeared. This precipitate
was collected by centrifugation.
Hydrolysis of lactose-APTS imine conjugate. The collected solid was suspended in 10 mL
of 20% aqueous acetic acid and stirred at 70 0C for 12 hours. A gradual dissolvation of
precipitate was observed during the reaction. Then, the solution was evaporated to dryness
under reduced pressure and the residual solid was suspended in 10 mL of water. The pH of
solution was raised to 9 by addition of 1M aqueous ammonia. Then, the solution was
extracted with chloroform (5 x 25 mL) to remove cyclen 1. The 1H NMR spectrum of the
aqueous layer showed only free APTS dye and free lactose peaks, indicating that hydrolysis
was successful.
Recovery of unlabeled lactose and APTS dye. The aqueous layer from the previous
experiment was evaporated and the residue was dissolved in 0.2 mL of 80% aqueous
methanol. APTS dye was precipitated by application of saturated solution of cyclen 1 in the
same solvent. The precipitate was removed by centrifugation, and the supernatant was
evaporated to dryness under reduced pressure. 1H NMR analysis of the solid residue revealed
only peaks consistent with label-free lactose. The remaining precipitate was dissolved in 10
mL of water, and back extracted with chloroform (5 x 25 mL). This extraction caused
partitioning of APTS-free cyclen 1 into the organic layer. Both organic and aqueous layers
were evaporated to dryness, and analyzed by 1H NMR. A solid residue from the aqueous
layer revealed only peaks consistent with APTS, and organic layer revealed only peaks
consistent with cyclen 1. Overall, 0.4 mg of lactose, 0.9 mg of APTS and 7.2 mg of cyclen 1
was recovered.
Synthesis of functionalized cyclen receptor following scheme 4.1
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Bromoacetic Acid 2-t-Butoxycarbonylaminoethyl Ester i. tert-Butyl-N-(2-hydroxy ethyl)
carbamate (4.5 g, 28 mmol) was dissolved in dichloromethane (30 mL), and triethylamine
(3.9 mL, 28 mmol) was added. The mixture was stirred for 10 min at room temperature, and
bromoacetyl bromide (3.15 mL, 36 mmol) was added dropwise within 5 min. The reaction
mixture was stirred for 5 h at room temperature, the solvent was removed under reduced
pressure, and the crude solid was purified by column chromatography (silica gel,
CH2Cl2/EtOAc 4:6) to give 7.0 g of i (25 mmol, 90%). 1H NMR (300 MHz, DMSO) δ 7.03 –
6.91 (q, J = 6.0, 5.4 Hz, 1H), 4.22 – 4.03 (m, 4H), 3.26 – 3.12 (p, J = 5.4 Hz, 2H), 1.50 – 1.35
(d, J = 4.1 Hz, 9H). ESI-MS calcd for C9H16BrNO4Na (M+Na+), 304.01; found 304.02.

tetrakis(2-((tert-butoxycarbonyl)amino)ethyl)2,2',2'',2'''-(2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (9). To a solution of p-NO2-Bn-Cyclen
(40mg, 0.13 mmol) in 10 ml of dry DMF was added Na2CO3 (110mg, 1.04mmol), followed
by addition of Bromoacetic Acid 2-t-Butoxycarbonylaminoethyl Ester arm i ( 230mg, 1.04
mmol). The reaction solution was first stirred at 600C for 6hrs followed by overnight stirring
at room temperature. The solvent was removed under reduced pressure and the crude solid
was purified by column chromatography (silica gel, 2-6% MeOH in CHCl3) to afford 79.65
mg (0.072 mmol, 55%) of precursor 9. 1H NMR (300 MHz, CDCl3) δ 8.22 – 8.10 (t, J = 9.2
Hz, 2H), 7.66 – 7.47 (dd, J = 26.7, 8.2 Hz, 2H), 4.39 – 4.04 (s, 8H), 3.58 – 3.43 (s, 10H), 3.40
– 3.34 (s, 10H), 3.03 – 2.91 (m, 2H), 2.20 – 2.08 (s, 4H), 1.48 – 1.38 (q, J = 3.5 Hz, 38H),
1.30 – 1.18 (m, 4H). ESI-MS calcd for C51H85N9O18Na (M+Na+), 1111.6; found 1134.6.

tetrakis(2-(3-(4-methoxyphenyl)ureido)ethyl)2,2',2'',2'''-(2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (10). The precursor 9 (170 mg, 0.152
mmol) was dissolved in 5 mL of CH2Cl2, and trifluoroacetic acid (2.4 mL of 50% v/v
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solution in CH2Cl2) was added dropwise. The reaction mixture was stirred for 6 h at room
temperature, and the solvent and excess of trifluoroacetic acid were removed under reduced
pressure to afford crude deprotected cyclen tertrafluoroacetate. Deprotected cyclen was
reacted without further purification. The crude was dissolved in 10 ml of isopropyl alcohol
and 4-Methoxyphenyl isocynate (182.4 mg, 1.22 mmol) was added to this solution. After 15
minutes, triethylamine was added slowly to bring the pH to 9. White precipitate produced
with the addition of triethylamine and acetonitrile was added to dissolve all the solid.
Reaction was stirred at room temperature for 16 hours and then evaporated to dryness under
reduced pressure. The crude was purified by column chromatography (silica gel, 2-6%
MeOH in CHCl3) to afford 79.95 mg (0.061 mmol, 40%) of functionalized OMe receptor 10 .
1

H NMR (400 MHz, DMSO) δ 8.45 – 8.39 (d, J = 3.4 Hz, 4H), 8.21 – 8.15 (d, J = 8.4 Hz,

1H), 7.65 – 7.55 (d, J = 8.3 Hz, 2H), 7.32 – 7.23 (m, 8H), 6.85 – 6.75 (m, 8H), 6.22 – 6.14 (q,
J = 5.0 Hz, 4H), 4.15 – 4.00 (q, J = 5.2 Hz, 8H), 3.72 – 3.63 (dd, J = 1.4, 0.8 Hz, 12H), 3.62 –
3.44 (ddd, J = 29.0, 14.2, 5.5 Hz, 6H), 3.22 – 3.03 (m, 37H), 2.94 – 2.87 (m, 6H). ESI-MS
calcd for C63H82N13O18 (M+H+), 1308.58; found 1308.50.

Alternative scheme for the synthesis of functionalized OMe receptor:
1-(2-hydroxyethyl)-3-(4-methoxyphenyl)urea (partial arm). To a solution of 4Methoxyphenyl isocynate ( 1.0 g, 6.7 mmol) in 15 mL of ethylacetate was added
ethanolamine (0.404 ml, 6.7 mmol). A white precipitate formed with the addition of
ethanolamine. The reaction mixture was stirred for two hours at room temperature and then
evaporated to dryness under reduced pressure to afford (1.365 g, 6.5 mmol) “partial arm” in
98% yield. 1H NMR (300 MHz, DMSO) δ 8.36 – 8.29 (s, 1H), 7.33 – 7.20 (m, 2H), 6.92 –
6.73 (m, 2H), 6.11 – 6.00 (t, J = 5.5 Hz, 1H), 4.78 – 4.66 (qd, J = 3.8, 2.8, 1.4 Hz, 1H), 3.76 –
3.63 (m, 3H), 3.51 – 3.25 (m, 2H), 3.23 – 3.05 (dtd, J = 6.7, 5.5, 1.2 Hz, 2H). 13C NMR (75
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MHz, DMSO) δ 156.33 – 156.07 (s), 154.65 – 154.39 (s), 134.50 – 134.23 (s), 120.08 –
119.82 (s), 114.69 – 114.42 (s), 61.29 – 61.03 (s), 55.93 – 55.66 (s), 42.63 – 42.37 (s). ESIMS calcd for C10H15N2O3 (M+H+), 211.1; found 211.15.
2-(3-(4-methoxyphenyl)ureido)ethyl 2-bromoacetate (complete arm). To the partial arm
(1.4097 g, 6.7 mmol) dissolved in 100 ml of CH2Cl2 was added triethylamine (1.0311 ml,
7.39 mmol). The mixture was stirred for 10 min at room temperature, and
bromoacetyl bromide (1.033 mL, 11.97 mmol) was added dropwise within 5 min. The
reaction mixture was stirred for 5 h at room temperature, the solvent was removed under
reduced pressure, and the crude solid was purified by column chromatography (silica gel, 25% MeOH in CHCl3) to give 1.99 g of “complete arm” (6.02 mmol, 90%). 1H NMR (300
MHz, DMSO) δ 8.39 – 8.33 (s, 1H), 7.34 – 7.17 (m, 2H), 6.87 – 6.73 (m, 2H), 6.21 – 6.10 (t,
J = 5.9 Hz, 1H), 4.20 – 3.95 (m, 4H), 3.73 – 3.65 (d, J = 0.9 Hz, 3H), 3.40 – 3.22 (m, 2H).
13

C NMR (75 MHz, DMSO) δ 168.01 – 167.75 (s), 156.26 – 155.99 (s), 154.85 – 154.58 (s),

134.25 – 133.98 (s), 120.39 – 120.13 (s), 114.67 – 114.41 (s), 65.93 – 65.67 (s), 55.91 –
55.65 (s), 38.88 – 38.61 (s), 28.01 – 27.75 (s). ESI-MS calcd for C12H15BrN2O4Na (M+Na+),
353.02; found 353.05.
tetrakis(2-(3-(4-methoxyphenyl)ureido)ethyl)2,2',2'',2'''-(2-(4-nitrobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (10). To a solution of p-NO2-BnCyclen (40 mg, 0.13 mmol) in 15 ml of dry DMF was added K2CO3 (160 mg, 1.15 mmol).
The reaction was stirred for 15 min and a solution of complete arm (400 mg, 1.2 mmol) in 10
ml of dry DMF was added over a period of 30 min. The reaction was then stirred for 6 h at
room temp. Excess solvent was removed under reduced pressure and crude was purified by
column chromatography (silica, 2-5% MeOH in CHCl3) to afford 105.6 mg (0.08 mmol,
62%) of functionalized OMe receptor 10. 1H NMR (400 MHz, DMSO) δ 8.45 – 8.39 (d, J =
3.4 Hz, 4H), 8.21 – 8.15 (d, J = 8.4 Hz, 1H), 7.65 – 7.55 (d, J = 8.3 Hz, 2H), 7.32 – 7.23 (m,
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8H), 6.85 – 6.75 (m, 8H), 6.22 – 6.14 (q, J = 5.0 Hz, 4H), 4.15 – 4.00 (q, J = 5.2 Hz, 8H),
3.72 – 3.63 (dd, J = 1.4, 0.8 Hz, 12H), 3.62 – 3.44 (ddd, J = 29.0, 14.2, 5.5 Hz, 6H), 3.22 –
3.03 (m, 37H), 2.94 – 2.87 (m, 6H).

13

C NMR (75 MHz, CDCl3) δ 174.45 – 173.69 (m),

157.25 – 156.88 (d, J = 7.4 Hz), 155.55 – 155.17 (d, J = 8.6 Hz), 147.27 – 147.00 (s), 146.85
– 146.50 (d, J = 6.0 Hz), 132.69 – 132.12 (dt, J = 12.5, 6.5 Hz), 130.15 – 129.76 (s), 124.27 –
123.92 (d, J = 6.7 Hz), 121.65 – 120.62 (h, J = 10.2, 7.9 Hz), 114.31 – 113.99 (s), 64.99 –
64.32 (m), 55.63 – 55.37 (s), 55.10 – 54.58 (m), 52.99 – 52.72 (s), 49.74 – 49.48 (s), 49.15 –
48.79 (d, J = 7.2 Hz), 48.44 – 48.17 (s), 48.12 – 47.85 (s), 38.76 – 38.50 (s), 32.17 – 31.91
(s). ESI-MS calcd for C63H82N13O18 (M+H+), 1308.58; found 1308.50.
tetrakis(2-(3-(4-methoxyphenyl)ureido)ethyl)2,2',2'',2'''-(2-(4-aminobenzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (11). To the solution of 10 (105 mg,
0.08 mmol) in 25 ml of dry THF was added Sn (170 mg, 1.44 mmol). The reaction was
stirred and HCl gas was passed through this solution. The solution became turbid with the
passage of HCl gas. Continued passing HCl gas and after two h solution became clear. Passed
HCl gas for another two h and then solvent was removed under reduced pressure to afford a
colorless, viscous liquid. An ammonical ethyalacetate solution was added to this viscous
liquid to make pH 10. A white solid was formed with the addition of ammonical ethylacetae,
which was then centrifuged and solid was separated. Solid was then sonicated with 20 ml of
10% MeOH in CHCl3 for 15 min. This solution was then centrifuged and clear solution was
collected. It was then dried under reduced pressure to give a crude solid, which was purified
by column chromatography (silica, 2-6% MeOH in CHCl3) to afford 64.63 mg (0.051 mmol,
63%) of reduced functionalize OMe receptor 11. 1H NMR (300 MHz, DMSO) δ 8.51 – 8.40
(q, J = 5.1, 4.4 Hz, 4H), 7.36 – 7.21 (m, 8H), 6.90 – 6.74 (t, J = 9.7 Hz, 10H), 6.52 – 6.43 (d,
J = 7.8 Hz, 2H), 6.32 – 6.21 (m, 4H), 4.33 – 3.91 (m, 8H), 3.71 – 3.51 (m, 16H), 3.50 – 3.37
(m, 2H), 3.28 – 3.20 (m, 14H), 2.99 – 2.92 (s, 4H), 2.77 – 2.70 (s, 8H). 13C NMR (75 MHz,
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CDCl3) δ 174.25 – 173.90 (d, J = 6.1 Hz), 157.29 – 157.03 (s), 155.47 – 155.20 (s), 132.74 –
132.35 (d, J = 9.7 Hz), 121.58 – 120.77 (m), 116.04 – 115.78 (s), 114.29 – 114.03 (s), 64.85
– 64.39 (d, J = 11.8 Hz), 55.66 – 55.40 (s), 55.10 – 54.80 (m), 50.21 – 49.95 (s), 49.90 –
49.63 (s), 48.65 – 48.30 (m), 38.76 – 38.50 (s), 32.81 – 29.58 (s). ESI-MS calcd for
C63H83N13O16Na (M+Na+), 1300.61; found 1300.72.
4-oxo-4-((4-((1,4,7,10-tetrakis(2-(2-(3-(4-methoxyphenyl)ureido)ethoxy)-2-oxoethyl)1,4,7,10-tetraazacyclododecan-2-yl)methyl)phenyl)amino)butanoic

acid

(12).

To

a

solution of compound 11 (35 mg, 0.027 mmol) in 6 ml of CH2Cl2 was added succinic
anhydride (8 mg, 0.08 mmol), followed by an addition of 3 ml of dry THF. The raction was
stirred at room temperature for 12 h. The reaction mixture was dried under reduced pressure
and the crude was purified by column chromatography (silica, 10% MeOH in CHCl 3) to
afford 29.74 mg (0.021 mmol, 80%) of compound 12. 1H NMR (300 MHz, DMSO) δ 8.51 –
8.41 (d, J = 6.8 Hz, 4H), 7.54 – 7.45 (m, 2H), 7.36 – 7.20 (m, 8H), 7.18 – 7.06 (t, J = 8.1 Hz,
2H), 6.84 – 6.72 (m, 8H), 6.30 – 6.21 (d, J = 8.0 Hz, 4H), 4.33 – 3.89 (hept, J = 11.8, 9.7 Hz,
12H), 3.71 – 3.57 (d, J = 3.2 Hz, 12H), 3.21 – 3.13 (d, J = 5.1 Hz, 8H), 2.98 – 2.86 (m, 2H).
13

C NMR (75 MHz, CDCl3) δ 155.50 – 155.24 (s), 132.59 – 132.32 (s), 121.35 – 121.09 (s),

114.31 – 114.05 (s), 68.23 – 67.97 (s), 64.89 – 64.41 (d, J = 15.9 Hz), 55.68 – 55.41 (s),
50.54 – 50.27 (s), 50.19 – 49.92 (s), 48.53 – 48.27 (s), 38.83 – 38.57 (s). ESI-MS calcd for
C67H88N13O19 (M+H+), 1378.62; found 1378.60.
tetrakis(2-(3-(4-methoxyphenyl)ureido)ethyl)2,2',2'',2'''-(2-(4-(4-((3-((tertbutoxycarbonyl)amino)propyl)amino)-4-oxobutanamido)benzyl)-1,4,7,10tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate (13). To a solution of 12 (25 mg,
0.018 mmol) in 10 ml of dry DMF was added EDC (3.6 mg, 0.024 mmol), followed by
addition of N-Boc-1,3-propanediamine (4.18 mg, 0.024 mmol). A catalytic amount of DMAP
was added. Reaction was stirred for 18 h at room temperature, the solvent was removed under
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reduced pressure to give a crude mixture. This crude mixture was purified by column
chromatography (silica, 2-6% MeOH in CHCl3) to afford 10.8mg (0.007 mmol, 40%) of
compound 13. 1H NMR (400 MHz, DMSO) δ 8.59 – 8.54 (s, 2H), 7.35 – 7.23 (tdd, J = 9.2,
7.0, 2.4 Hz, 7H), 7.15 – 7.06 (t, J = 6.9 Hz, 1H), 6.99 – 6.91 (t, J = 5.9 Hz, 3H), 6.84 – 6.73
(tt, J = 5.9, 1.8 Hz, 8H), 6.41 – 6.32 (m, 3H), 4.30 – 3.95 (m, 10H), 3.70 – 3.64 (d, J = 2.8
Hz, 10H), 3.46 – 3.38 (d, J = 8.2 Hz, 2H), 3.20 – 3.15 (s, 9H), 3.04 – 2.86 (m, 12H), 2.80 –
2.69 (dd, J = 8.6, 6.5 Hz, 9H), 1.25 – 1.17 (s, 10H). ESI-MS calcd for C75H103N15O20Na
(M+Na+), 1533.75; found 1556.60.
tert-butyl (3-aminopropyl)carbamate. To a solution of propylenediamine (0.675 ml, 8.1
mmol) in 40 ml of chloroform, a solution of Boc anhydride (353.3 mg, 1.6 mmol) in 10 ml of
chloroform was added dropwise over a period of 3hrs. Reaction was stirred for another 3hrs
at room temperature. Reaction was dried under reduced pressure and crude was purified by
column chromatography (silica, 4-8% MeOH in CHCl3) to yield 220 mg (1.2 mmol, 78.5%)
of the product. 1H NMR (300 MHz, CDCl3) δ 5.08 – 5.01 (s, 1H), 3.21 – 3.07 (q, J = 8.4, 7.0
Hz, 2H), 2.78 – 2.61 (q, J = 6.2, 5.8 Hz, 2H), 1.63 – 1.40 (m, 2H), 1.40 – 1.21 (s, 11H). 13C
NMR (75 MHz, CDCl3) δ 156.49 – 156.22 (s), 79.25 – 78.99 (s), 39.90 – 39.63 (s), 38.66 –
38.39 (s), 33.63 – 33.37 (s), 28.73 – 28.46 (s). ESI-MS calcd for C8H19N2O2 (M+H+), 175.14;
found 175.20.
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